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Abstract
Influenza viruses can infect a large variety of birds and mammals including humans,
pigs, domestic poultry, marine mammals, cats, dogs, horses, and wild carnivores [1].
Surveillance for influenza viruses circulating in humans has been gradually increased
and expanded to many areas around the world. These surveillance programs have
produced large amount of influenza genomic data which facilitates the study of the
virus by computational methods that are efficient and cost saving.
The main focus of this dissertation research is the development of visualization
methods to understand the evolution of influenza viruses circulating in humans and
other mammals. The methods developed have been applied to different human influenza
A subtypes, swine influenza viruses, and avian influenza viruses. The methods are
based on unsupervised dimensional reduction techniques which can be applied to each
individual genome segments or to the complete genome sequence of the virus. These
methods are a departure from the traditional phylogenetic tree construction paradigm
because very large number of high dimensional input sequences can be processed and
results are viewed directly in a two or three dimensional Euclidean space.
We reproduced the evolutionary trajectory of the seasonal human influenza A/H3N2
virus since its introduction to humans in 1968 on a 2D PCA space. The observed
pathway led us to hypothesize that vaccination serves as a primary evolutionary pressure
iv
on this virus. We provided visual, simulation results, and statistical results to support
this hypothesis.
The North American swine influenza H3N2 viruses were also studied using the de-
veloped visualization methods. The diversity of this virus is changing since the 2009
H1N1 pandemic outbreak. Five main clusters were observed from the visualization re-
sults. The mutations at two positive selected sites on the HA gene were identified as
the potential driver for clusters segregation of this virus after the pandemic.
A visualization method was developed to visually detect reassortant influenza virus.
A reassortant influenza virus is difficult to detect because it consists of genome segments
from different parental origin. As two different strains of influenza coinfect a single cell,
the capability to exchange genome segments between these two strains can lead to
progeny carrying different parental segments within its genome. In order to detect such
progeny, a PCA projection based visualization method that is able to examine the full
genome sequence of a reference and test strains simultaneously was developed in order
to detect any reassorted segments within a full genome.
Besides the development of visualization methods, we have also developed a compact
Markov Chain model to estimate the probability of viruses with high genetic similarity
found after a very large time gap. This model is a two components model where we
combined a Markov Chain with a Poisson model. The Markov model uses Hamming
distance as the evolution process of the virus and a computed mutation rate as the
input to the Poisson model, combined together, we simulated the evolution process of
v
the influenza virus under the neutral evolution process. The computational results from
this model led us to conclude that the existence of reservoirs preserving viruses for
decades cannot be completely eliminated.
In short, our primary goal has been to develop visualization based approaches to
understand the evolution of the influenza viruses from different hosts. The results we
have so far suggested that the power of visualization paves the way to gain deeper
understanding and insight of the evolution of the virus as we utilize the rapidly growing
amount of the genomic data of the virus.
vi
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Chapter 1
Introduction
1.1 Introduction
Computational biology utilizes a broad spectrum of computational techniques to study
varies problems arising from basic biology. As more genetic sequences become avail-
able for the model organisms, more basic research questions about the organisms can
be answered using computational methods instead of relying on time consuming and
costly benchwork. The model organism of this research study is the influenza virus
(IV). Influenza virus is a persistent threat to global health which can kill up to fifty
thousand people in the United States each year alone[2]. Influenza virus has been the
subject of active research and study throughout the past century. The World Health
Organization (WHO) Influenza Surveillance Network has established a network of in-
fluenza virus monitors and sample collection stations around the world to collect and
1
2analyzes virological and epidemiological data related to influenza outbreaks. A direct
consequence of this effort is the massive amount of influenza genetic sequences being
collected, accumulated and deposited to online databases. This, in turn, has provided
us with valuable data which makes the study of influenza virus through computational
approach possible. The central focus of this dissertation is the study of the evolution of
influenza virus by applying unsupervised statistical machine learning methods.
1.2 Problem of Interest
The main problem of interest is to study the evolutionary dynamics of the influenza
virus through the use of computational tools. Specifically, we are interested in the type
A influenza virus that circulates among humans and how does this type of virus evolves
within a protected environment. A glimpse of the problem being studied in this dis-
sertation arises from the observation presented in Figure 1.2. When hemaggluttinin
sequence samples originated from vaccinated avian H5 (1994-2002) influenza and un-
vaccinated avian H5 (1997-2002) influenza was subjected to polymorphism analysis, we
observed that the number of mutations were higher in the vaccinated sample than in
the unvaccinated sample. In addition, more mutations are observed at the region of
antibody binding sites. These sites are recognized by host’s antibodies. When muta-
tions are presented within these sites, antibody can no longer bind to the HA protein
for neutralization, thus the virus can become an immune escape mutant.
Observation from Figure 1.2, Figure 1.2 and Figure 1.3 led us to hypothesize that
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Figure 1.1: Hemaggluttinin protein from vaccinated and unvaccinated influenza sample
shows the number of mutations is larger in the vaccinated sample than in the un-
vaccinated sample. In addition, number of mutations are found to be higher in the
hypervariable region of the HA protein of the vaccinated sample.
influenza virus evolves differently in a vaccinated environment than in a unvaccinated
environment. In Figure 1.3, one sees the ’changing location’ of the high dN/dS ratio
sites as new vaccines are being introduced. A high dN/dS ratio (> 1) indicates the site
is under heavy selection pressure and that the mutations on such particular site con-
tributes to nonsynonymous changes that results in changes in the encoded amino acid.
The dN/dS ratio was computed using vaccine strain against each season’s dominant
circulating strain from year 1968 to 2009. From this figure, we see that whenever a shift
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Figure 1.2: Based on the hemaggluttinin protein from 1968-2010, human H3N2 influenza
sample shows that the p-distance is gradually increasing between the newer strains and
its oldest strain. Avian H5 virus sample shows the p-distance between the newer and
oldest strain stays at a constant throughout the 1968-2010 time period.
on the antigenic site (dN/dS ratio > 1) occurred, a new vaccine was introduced to tar-
get such antigenic variant. When the selection pressure remained the same on the same
antigenic sites from the previous season, a repeated vaccine was used. A study by [3]
indicated that the antigenic changes correspond to modifications in the virus and host
relationship. Other factors that can drive mutation that leads to antigenicity change of
the virus includes the rapid mutation rate of the RNA virus coupled with the lack of
an error correcting mechanism during the replication cycle. This can result in progeny
viruses with a fitness advantage that is able to survive the antibody neutralization from
the host.
Our primary research interest is to develop computational methods to investigate
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Figure 1.3: A/H3N2 HA gene. X-axis represents the location of each amino acid
residue of the HA1 domain of the HA gene. Y-axis represents time in terms of new
vaccine introductions (green squares) and repeated vaccine component (black square).
Blue color indicates the highest dN/dS ratio observed on the HA1 domain and red
color indicates a higher than average dN/dS ratio at the locations observed on the HA1
domain. The blue color squares are mostly located on the antigenic binding sites A and
B on the HA1 domain.
the evolution of the human influenza virus in both vaccinated and unvaccinated environ-
ment. This dissertation also encompasses three other areas of interest: antigenic drift
simulation using a stochastic model, reassortant detection based on a PCA projection
technique and cluster analysis of North American swine influenza viruses. These three
areas will bring depth to the study of the influenza virus and at the same time provide
a broader coverage in understanding the evolution of the influenza virus in general.
61.3 Contributions
The effectiveness of influenza vaccine has been studied by many researchers and the
focus has always remained to measure the vaccine effectiveness from the host’s point
of view. A subtle, yet important aspect that is often missed or not being studied is
the effect of vaccination have on the evolution of the virus itself. Limited studies [4, 5]
using phylogenetic analysis on very small number of avian samples collected within a
short time span indicated that vaccination could play a role in the evolution of the
virus. These studies have shown that antigenic drift of avian influenza viruses under
vaccination pressure are similar to those observed with human influenza viruses. The
findings from these studies encourage one to utilize the massive amount of collected
influenza genetic sequence data for further and more in-depth investigation into the
evolution of or antigenic drift of human influenza virus under vaccine pressure. Here,
we have taken a computational approach to the investigation of human influenza under
vaccine pressure as the main research objective. Below is a list of the contributions
made:
• Developed a compact Markov Model to model the evolution of H1N1 influenza
virus.
• Developed a high dimensional data visualization method to visualize the evolu-
tionary trend of human influenza virus.
• Developed a projection method to predict influenza reassortant virus by visual
7inspection.
• Provided computational evidence suggesting that influenza virus evolves differ-
ently in a protected environment than in the wild.
• Provided computational evidence which showed that North American swine H3N2
influenza virus segregation could be explained by two positively selected sites on
the Hemaggluttinin protein.
1.4 Limitations of the study
Often time, a research study is not without its limitations. There are a few unavoidable
limitations that can potentially affect the quality of this study. The first such limitation
in our study originates from the data source. The majority of the genetic sequences
that were used in the study were downloaded from the NCBI online influenza database
[6]. The database often contains incomplete or redundant sequences and the sparsity
of samples from early years which can make the study difficult. These issues can cause
bias in sequence database due to data curation bias or data sparsity. This bias is not
uncommon but can potentially impact the results of the study if not treated with care.
The second limitation are the factors that have not be considered in the study. These
factors include the difference in host’s life span, difference in the geographical location
of the sample collected and the difference in host species. The third limitation is the
extreme difficulty in finding vaccinated samples for the study. The fourth limitation is
8that our study did not use antigenic cartography to directly capture the vaccine antibody
associations. Our analyses were based on publicly available genetic sequences alone.
Other factors may also have played a role in driving the evolution of influenza. These
factors include host specific immune response, the large difference in life expectancy
between humans and avian species, vaccine efficacy and effectiveness, the transmission
channel of the virus in difference environment, and geographical regions. These factors
have not been considered in this present study because our overall objective is to present
a genetic sequence only approach as the first step in understanding the evolution of
influenza viruses in protected and wild environments.
1.5 Dissertation organization
The organization of this dissertation is as follows:
• Chapter 1 introduces goals and contributions to the field of computational in-
fluenza virus study and provides background information on influenza virus.
• Chapter 2 is a literature review chapter focuses on computational methods applied
to the study of influenza virus.
• Chapter 3 describes a novel Markov model used to model influenza virus evolution.
• Chapter 4 describes the binary encoding technique used to study the evolution of
influenza viruses.
9• Chapter 5 describes a PCA projection based reassortant virus detection method.
• Chapter 6 presents a cluster determinant analysis of the North American swine
influenza virus.
• Chapter 7 concludes this thesis with the final discussion and outlines the future
directions.
1.6 Influenza virus
The influenza virus (IV) has been the focus of intensive research for the past century
ever since the 1918 Spanish flu pandemic that killed from three to five percent of the
world population at the time. This is one of the most deadliest pandemics in human
history[7]. Influenza viruses have the ability to infect a very broad range of avian
and mammalian species. Their genomic diversity is acquired through two biological
mechanisms: antigenic drift (see section 1.6.1 and antigenic shift (see section 1.6.1).
Both antigenic drift and shift allow for the virus to evade host’s immune response and
can rapidly adapt to the new host [8]. Influenza virus belongs to the viral family Or-
thomyxoviridae and classified into five genera: influenza A, influenza B, influenza C,
Thogotovirus, and Isavirus [9]. All influenza viruses contain a segmented negative sense
single stranded RNA genome. Currently, there are 17 A subtypes (H1 to H17) identified
in the influenza A virus family. Influenza A has eight unique RNA segments [10] that
encode 11 different gene products (PB1 polymersae, PB2 polymerase, PA polymerases,
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PA-X polymerases, Hemagglutini (HA), Nucleoprotein (NP), Neuraminidase (NA), Ma-
trix M1 and M2 proteins, and Nonstructural NS1 and NS2 proteins. Table 1.1 lists the
eight segments of the influenza virus.
Table 1.1: Influenza genome
Segment Length (NT) Protein Name Encoded polypeptide
1 2341 Polymerase basic 2 PB2
2 2341 Polymerase basic 1 PB1
PB1-F2
3 2233 Polymerase acidic PA
PA-X
4 1778 Hemaggluttinin HA
5 1565 Nucleoprotein NP
6 1413 Neuraminidase NA
7 1027 Matrix 1 M1
Matrix 2 M2
8 890 Nonstructural 1 NS1
Nonstructural 2 NS2
1.6.1 Evolution of Influenza A Virus
The evolution of influenza A virus is driven by two fundamental mechanisms: high
rate of mutations and the ability to reassort gene segments. Gene reassortment is the
exchange of the complete matching gene segments between two or more influenza viruses.
This often give rise to the emergence of reassortant viruses and it is termed antigenic
shift. For example, when the surface HA and NA genes are swapped, a new subtype of
influenza [11] virus can emerge. Due to the lack of error correcting mechanism during
replication [12, 13], difference genotypes can emerge that have the ability to survive
11
within the host. This mutational change in the viral genomic sequence caused by high
rate of mutations over time allows influenza virus to escape antibody neutralization. The
HA and the NA genes of the surface proteins of the virus are most likely to undergo
mutation over time [14, 15].
Antigenic drift
Antigenic drift is the term that is often used to describe the mutations on the surface
proteins of the influenza virus. The changes usually are found on the antibody binding
sites of the HA protein. Once sufficient changes are made or accumulated, the antigenic-
ity of the virus will change leading to a new antigenic variant. Antigenic cartography
technique is used to establish the antigenicity of a virus. The data for constructing the
cartography can come from HI binding assay or micro-neutralization assy tests of the
homologous and heterologous HA types on sera from vaccinated individuals. The major
concern about antigenic drift is that the human seasonal influenza vaccines requires
yearly reformulation in order to provide protected immunity from the new antigenic
strains [16, 17].
Antigenic shift
Antigenic shift is the ability of the virus to reassort gene segments and it is often thought
of as the mechanism of introducing an antigenically distinct virus within a population
that is different from currently circulating strains [16]. A reassortment event can take
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place when a host cell is co-infected by two different influenza subtypes. Due to the
segmented genome, influenza viruses can easily ’swap’ their complete individual gene
segments between one and another during replication. The reassorted virus can spread
rapidly within human population and sometimes lead to a pandemic [7]. The most
recent pandemic is the H1N1 swine origin from 2009 which originated from Mexico and
spread around the globe within a very short time. The 2009 H1N1 swine pandemic
virus H1N1pdm09 is a reassortant of genes (PB1, PB2, PA, HA, NP, and NS) from
North American swine lineage and genes (M and NA) from Eurasian swine lineage [18].
A more recent reassortment event is the emergence of H3N2 variant, a classical TRIG
virus that infects swine reassorted with pdmH1N109 to acquire the pandemic matrix
gene [19]. These H3N2v strains have a higher velocity of spread within pig populations
and has been reported in zoonotic transmission to humans [20].
1.6.2 Hemaggluttinin gene
Hemaggluttinin (HA) is the major envelope glycoprotein of the influenza A virus. The
classification of influenza A virus into different subtypes is based on the antigenic speci-
ficity of each individual HA. Antigenic specificity refers to the ability of the immune
system to recognize an antigen as a unique molecular entity and differentiates it from
the other [21]. During membrane fusion, HA is cleaved into HA1 (about 329 amino
acids) and HA2 (about 237 amino acids). The HA1 is a receptor binding protein and
the major target of immune responses. HA2 is an anchor protein that mediates the
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fusion of protein envelope and the cellular endosomal membrane [22, 23].
The virulence and pathogenicity of influenza A virus are often associated with its
hemagglutinin gene. The human influenza A H3 protein is said to have five specific
epitope regions (A, B, C, D, and E located on the globular head of the HA protein [24].
These regions tend to accumulate amino acid changes due to antigenic drift over time
and eventually preventing antibody binding to the epitope region. This allows the virus
to escape the host immune response and continue its replication and transmission.
Understanding the evolution of the HA genes is importance as it is a target of the
current influenza vaccine. In terms of genetic similarity among all the HA subtypes,
H13 and H16 share high degree of genetic similarity. H7 and H15 also are very similar
in their genetic composition [25, 26]. Chen et. al., also showed that human influenza
viruses have diverged into difference clades during the past decades. Results from Chen
et. al., suggested that human viruses update rapidly and the viruses are maintained
almost exclusively by humans themselves[26]. In total, 60 lineages and 83 sublineages
within influenza A virus circulating around the globe based on HA protein alone have
been identified by phylogenetic analysis [26].
1.6.3 Internal proteins
Although our research is focused on the surface proteins of the virus, a short back-
ground introduction of the internal genes of the virus is necessary. Influenza genome
segments 1, 2, 3, 5, 7, and 8 encode the internal genes of the virus. The functions of
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all the internal genes are not fully understood. Influenza polymerase proteins (PB1,
PB2 and PA) encoded by segments 1, 2, and 3 are responsible for the replication of the
eight different uncapped, non-polyadenylated, negative-sense RNA segments (vRNAs)
that make up the viral genome [9]. Prior to translation by the host cell, a negative
sense (3’ to 5’) viral RNA needs to be first transcribed into a positive sense RNA by an
RNA polymerase. The nonstructural proteins NS1 and NS2 encoded in segment 8 are
thought to be associated with the pathogenicity of the virus. Studies have shown that
influenza virus with partial deletions in NS1 proteins are attenuated and do not cause
disease [27, 28]. The attenuated influenza virus through partial deletions of the NS1
protein presents a different pathway through which live attenuated influenza vaccines
for human can be designed and developed [29]. The NP protein is encoded by seg-
ment 5 and its primary function is to encapsulate the virus genome for the purposes of
RNA transcription, replication and packaging [9]. Phylogenetic analysis of virus strains
isolated from different hosts reveals that the NP protein is relatively well conserved
across time, with a maximum amino acid difference of less than 11 percent [30]. Its
role in the influenza virus life cycle involves polymerase interactions, M1 interactions,
and Homo-oligomerization/NPNP interactions [30]. The broad spectrum of activities of
this protein suggests that this NP gene is a key functional component of the virus. The
membrane proteins M1 and M2 of influenza A viruses are thought to have established
four major host related lineages based on phylogenetic analysis: (1) Equine, which has
the most divergent M gene; (2) a lineage containing only H13 avian viruses; (3) a lineage
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containing both human and classical swine viruses; and (4) an avian lineage subdivided
into North American avian and avian viruses in general [31]. The M1 protein is evolving
very slowly in all lineages, whereas the M2 protein shows significant evolution in human
and swine lineages but virtually none in avian lineages[31]. The M protein is also a
proton gating apparatus on the virion and is critical to viral replication. This feature
may explain why M protein alone of pandemci H1N1 confers a wider host range.
1.7 History of Influenza Virus and Vaccine
Currently there are two dominant influenza A subtypes (A/H1N1 and A/H3N2) that
are circulating in human populations. The A/H1N1 has the longest history since its
first emergence in humans during the 1918 Spanish flu pandemic outbreak [32, 33].
The A/H1N1 abruptly disappeared from humans in 1957 and reappeared in 1977 in
the former Soviet Union, Hong Kong, and northeastern China [33]. The disappearance
of A/H1N1 was due to the replacement by the A/H2N2 strain which contained mixed
genome segments from avian source and the A/H1N1 strain of 1918 Spanish pandemic
lineage. A/H2N2 circulated in humans from 1957 to 1977 until A/H1N1 was detected
again in 1977. The reason for the complete disappearance of this A/H2N2 was not clear
[33]. A new A/H1N1pdm09 strain that caused the 2009 pandemic was first discovered
in Mexico in the April of 2009 and spread around the globe in less than six months
[34]. This new A/H1N1/pdm09 contains gene segments from triple reassortant swine
influenza virus lineage and Eurasian influenza A (H1N1) swine virus lineage. This new
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A/H1N1pdm09 is now the dominant A/H1N1 subtype circulating in human populations
since 2009. Influenza A/H3N2 appeared in Hong Kong in 1968 and it has been in
continual global circulation ever since. Although A/H3N2 strains appeared later than
the A/H1N1 strains, there have been well over 20 annual vaccine updates associated
with this virus since its outbreak in 1968. This shows that this virus has a much
higher antigenic drift rate than the A/H1N1 and any other vaccine controlled influenza
viruses. The fast rate of antigenic drift of this virus has remained one of the most
challenging questions to date [35]. Influenza B emerged in the late 1970s and split
into two antigenically distinct lineages since the early 1980s. These two lineages are
referenced as Vic87 and Yam 88 respectively [36]. The viruses from these two antigenic
distinct lineages have been cocirculating in human populations in particular time and
regions [37]. Influenza B virus mutates at a rate that is 2 to 3 times slower and is
genetically less diverse than influenza A [38].
To keep track of the evolution of the virus, annual update to the influenza vaccine
composition is needed in order to provide a vaccine induced immunity to the general
public [39]. The main process in influenza vaccine strain selection is to assess the
match between the vaccine strain and the currently circulating strains and the potential
new antigenic variant [17]. If the vaccine strain does not match the currently circulating
strains or the new antigenic variant that is likely to be the major variant in the upcoming
influenza season, the vaccine composition is updated to contain a representative of the
new variant [17]. Each vaccine update is designed to provide immunity to the new
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antigenic variant that has emerged from the previous flu season. The seasonal influenza
vaccine is used to prevent the infection and transmission of the virus, but its effect on
the evolution of the virus itself is not clear.
Avian influenza (AI) or bird flu, is an infectious viral disease of birds, and most do
not infect humans. Historically, human infections with avian influenza viruses have been
rare and most of these viruses have caused only mild illness [40]. However, AI H5N1 and
H7N9 have caused infections in people that have led to death [41, 42]. The majority of
these cases of A(H5N1) and A(H7N9) infection have been found to be tied to the direct
contact with live or dead poultry by the victims [41, 42]. Avian influenza A outbreaks
occur in poultry from time to time around the world and in North America. Culling or
depopulation of infected flocks is usually the preferred control and eradication methods
when avian H5 or H7 influenza outbreaks occur in poultry. The usage of vaccination
to control and to prevent infection from avian influenza viruses in poultry is generally
banned or discouraged [43]. However, vaccination against the avian H5 and H7 influenza
viruses in several occasions in recent years with the general objective of controlling and
in some cases eradicating the disease has been used in isolated outbreaks in poultry
farms. This does not mean that vaccination program against avian influenza viruses
has been widely adapted or implemented across different poultry farms or regions. This
is because vaccination as the primary control method has been unsuccessful on the larger
scale [44, 45, 46, 47, 48, 43].
Chapter 2
Background and Review of
Literature
2.1 Introduction
This chapter reviews the current computational methods used in studying influenza
virus. The purpose is to elaborate on the specifics of the current methods so that
alternative methods offered by the current research can be properly assessed and valued.
This review focuses on methods that work at the primary structural (sequence) level of
the influenza virus, computational methods that target the secondary structure of the
virus will be described if they serve to validate the results generated from sequence level
analysis.
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2.2 Genetic sequence data
We are interested in direct sequence conversion, which is the ’first source approach’
instead of the ’second source approach’. For example, a second source approach is to
give the pairwise hamming distance between each sequence in the dataset and subse-
quent data processing steps are performed based on the pairwise distance matrix.Data
exploration as the initial step in analysis is beneficial and useful when little is known
about the data. When presented with large datasets, visualization is often used as the
first step in data exploration. A large dataset can be either large in size or high in
dimensionality or both. A good visualization method can often reveal structure, trends,
outliers, hidden patterns, and relationships in the dataset. Once an initial understand-
ing of the data is achieved, one can often make hypothesis about the study at hand.
Thus, initial data visualization can be viewed as a hypothesis generation process. There
are a few properties a good visualization should facilitate: (1) finding outliers, finding
connections, finding patterns, or reveal hidden structure of the data; (2) finding sparse
representation of the data while minimizing information loss; and (3) diagnostics for
model fit and evaluation. These three are often the main objectives in performing data
visualization but depending on the nature of the data or application, one is often faced
with the challenge of achieving all three in one go [49, 50].
Many methods can be utilized to visualize a dataset on a two dimensional screen
that are both effective and cost saving (in terms of time) in data exploration. For
this chapter, we concentrate on presenting high dimensional data visualization methods
20
based on unsupervised machine learning approaches. The reason is that unsupervised
approaches often require minimal manual intervention and understanding of the data at
hand. Unsupervised visualization method if done properly can provide good qualitative
overview of the large and complex data or even help in identifying regions of interest
for focused analysis. For example, clustering and classification algorithm coupled with
visualization can help to generate a visual aid that serves as a rough blueprint or guide
to provide users with insights. This type of visual aid can be very useful in order to
have a better understanding of the data in order to make better decisions involving any
further quantitative analysis.
Computational methods that operate at the sequence level often are presented with
a few limitations. The first limitation is not from the method itself but rather it is
originated from the data source. Most often it is commonly known to be the data
source bias problem. Influenza surveillance programs give top priority to antigenic
novel isolates to be sequenced and deposited to databases which may cause sample
bias problem in the data. The prioritization of isolates means that sequences were
deposited to the database that are not representative of the overall influenza community
cases. If the study is targeted toward a specific issue dealing with a specific influenza
virus subtype, then this type of problem is not as damaging to the result. The second
limitation is that not every sequence that is available in the database is a complete
sequence, meaning that partial sequence that is considered to be ’important’ or contains
antigenic sites of the virus is sequenced and made available. For example, HA gene has
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two domains, HA1 and HA2 domain respectively. Often time only HA1 portion which
is the most variable portion of the complete HA sequence is available for download.
A third limitation is that a sequence can be a mixed subtype sequence, this type of
sequence is not commonly found in the database but they do present a special challenge
in the sense that it is a mixed infection sequence and unless a specific study concerning
mixed infection otherwise sequence like this is best removed from the dataset.
Datasets that are not easily presented using two or three dimensional visualization
techniques (bar graph, charts, histogram, line plots, scatter plots) are often more difficult
to handle and can demand more computational resources. Such datasets are usually
of very high dimension and very large in size. These type of dataset often presents
challenges both to researchers and computational resources respectively. Often, this
type of data starts out as a very large matrix either dense or sparse in nature. The
visualization of this large matrix is complicated by the noise embedded in the data
which is not obvious to the data analyst. In this chapter, we focus on the gene genetic
sequence data of influenza viruses.
Genetic sequence data usually consists of long strings of alphabets which can not
be easily represented by numbers. For example, influenza hemaggluttinin nucleotide
sequence consists of 1698 (566 amino acids) bases and horizontal scrolling is needed
when viewing the sequences or sequence alignment on the screen. For simple content
visualization of any genetic sequences, there are software that can display multiple
sequence alignment or some simple Matlab programs [51] that can help to display the
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profile of a set of sequences. For example, figure 2.1 below shows a visual profile of
a set of influenza protein sequences. This profile view gives a quick rough ’feel’ of the
genetic composition of this set of sequences. The y-axis has the twenty amino acids
and the x-axis represents the positions of the sequence. Depends on the application at
hand, visualization of genetic sequences often sought to reveal sites that are related to
the function of the protein. Sites that are conversed are often thought to be related to
the core function of the protein while sites that show variation are thought to be not
important in maintaining the function of the protein.
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Figure 2.1: Sequence profile of an influenza HA protein.
Often, a conversion method can be used to convert each letter or each sequence
into a numerical vector. The length of the numerical vector depends on the conversion
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scheme used and often time a trade off exists in the conversion scheme such that all
important information of the genetic sequences may not be captured. Here, we list
a few conversion schemes that have been applied to convert genetic sequence data to
numerical vectors for computation.
k-mer vector
The k-mer vector converts a genetic sequence to a vector by using the k subsequence
to describe the data. For a nucleotide sequence, it is converted to a vector of length
4k where 4 equals the number of letter in the alphabet [AGCG]. If k = 3, then the
vector length is 43 = 64. The k-mer conversion scheme also works on protein sequences
with the converted vector length of 20k. The higher the k value, the longer the vector.
However, often this k-mer scheme is applied to the nucleotide sequences. All the genetic
sequences converted to numerical vectors can form a matrix of size M − by−N with M
being the number of sequences and N = 2k the features. Standard algorithms can then
be applied to this matrix for analysis purposes. A drawback of this conversion scheme is
that certain positions on a genetic sequence may carry specific signal or play a functional
role in the organism’s evolution or life cycle and this information is not captured with
the k −mer conversion method. It is because any genetic sequence is broken up into
k −mer subsequences and any positional signal is lost during the conversion process.
24
Codon vector
There are 64 genetic codes and each code defines how sequences of the nucleotide triplets,
called codons, translates into amino acid. The codon vector scheme converts a nucleotide
sequence into a numerical vector of length 64. Each component of the vector is a
codon count of the nucleotide sequence. A M by 64 data matrix where M is the
number of rows can then be constructed for analysis. Again, this scheme does not
preserve positional information from the sequence and any significant information will
be lost during the conversion process. As an example, a visualization of influenza
sequence data based on this approach is illustrated in figure 2.2. The visualization
was performed using Principal Component Analysis [52] on the data matrix and the
top three principal components were selected for visualization purpose. Three different
subtypes of influenza virus sequences were used in this example. As can be seen in the
figure, distinct clusters can be observed which suggested that the genetic composition
or genotype of these three subtypes is different. A small cluster of human H1N1 can
be seen off to the lower center below a bigger cluster of the same subtype. This could
indicate that the human H1N1 virus had evolved into a different genetic makeup. This
example illustrates that the codon vector scheme can capture the genetic fingerprint of
three subtypes of influenza viruses even those positional information was not kept.
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Figure 2.2: Visualization based on codon vector approach.
2.3 Computational methods
Here, we give a brief introduction on a few computational methods that have been
developed to study influenza viruses. These methods shared a common theme in that
they all utilized techniques from unsupervised machine learning paradigm. Detail for
each method is provided in subsequent sections. Smith et. al [16] produced an antigenic
map (cartography) showing the antigenic evolution of influenza A (H3N2) virus from
its introduction into humans in 1968 to 2003. The map was generated using hemag-
glutination inhibition (HI) binding data utilizing a classical multidimensional scaling
method[52] which revealed clusters of viruses along a chronological path from 1968 to
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2003. Using computational method to predict evolution of the virus based on cartog-
raphy took on a more comprehensive approach when Cai et. al [53] demonstrated that
combining multiple HI datasets gave more accurate result which can be used favorably
to predict vaccine strain. Their approach can be thought of as a two steps process in
which they: (1) reduce the full rank HI data matrix by Singular Value Decomposition
(SVD) to give a low-rank approximation of the data and (2) perform multidimensional
scaling on the low-rank data to generate the cartography map of the virus. Because of
combination of multiple HI datasets, the results were shown to be more accurate both in
simulated and real HI data. The cartographic map successfully captures the evolution
of the virus and it shows that influenza viruses tended to form clusters along a path.
The cluster formation of the virus was first shown by [54] using a simple single-linkage
clustering algorithm [52] based on the pairwise Hamming distance of the HA sequences
downloaded from the NCBI influenza database [6]. Adapting unsupervised clustering
algorithm to study influenza viruses have become more common.
2.4 Cluster Analysis
In 1992, a cluster analysis of 560 influenza H3 HA1 nucleotide sequences from 1968 to
2000 was performed using a single-linkage clustering algorithm by Plotkin et al., [54].
This is the first study using a clustering algorithm to cluster influenza virus sequences
into disjoint groups. Their results suggested the existence of a natural scale of non-
random aggregation of viral swarms. The viral swarms were closely matched to the time
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series of the influenza vaccines recommended by World Health Organization (WHO) for
influenza seasons. Through the cluster analysis, they also proposed a simple vaccine
selection scheme based on a distance of 6(2) nucleotide(amino acid) changes between
clusters. The most recent virus in the current season’s most dominant cluster is selected
as the vaccine strain for next flu season. Further, they showed that pattern of epitope
changes corresponded to cluster jump. Each cluster jump was dominated by mutations
on different epitope.
2.5 Influenza Antigenic Distance
The antigenic differences between influenza strains are quantified by the hemaggluti-
nation inhibition (HI) assays. These antigenic differences can be used as ’distance’
between vaccine strains and current circulating strains when selecting vaccine strains
for vaccine production. The antigenic measurement is best described by Ndifon [55]
as: The degree to which antisera extracted from individuals infected by one strain (the
infecting or homologous strain) prevent another strain (the heterologous strain) from
agglutinating red blood cells (heterologous HI titer) is used to measure the antigenic
difference between the two virus strains. However, HI titers measured in HI assays can
be quite variable due to the fact that HI titers depend on factors, such as: capacity of
strains to induce the production of antibodies [56], experimental conditions (temp, pH,
etc), and the properties that are not directly related to antigenic difference.
Because of the variability issues in HI assays, sequence based distance measures
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have been developed to evaluate the degree of match between the vaccine strains and the
dominant circulating strains [57, 58]. The first such distance measure, Pepitope, considers
only the antibody binding sites on the H3 HA surface protein. To use this Pepitope, one
must know the dominant epitope of the HA under consideration. According to [57], a
dominant epitope can be identified as the antibody binding site of a circulating strain
with the largest fractional change in amino acid sequence relative to the vaccine strain.
This measure is almost identical to the p-distance (hamming distance over the total
length of the sequence) commonly used in molecular evolution except we are considering
a small portion of the sequence to calculate the hamming distance. Pepitope =
h
N
where h
is the number of amino acid differences in dominant epitope and N is the total number
of amino acids in the dominant epitope. Pan et. al., extended this formulation to
Pall−epitope =
hˆ
Nˆ
where hˆ is the number of changes in all five epitopes and Nˆ is the total
number of amino acids in all five epitopes.
2.6 Influenza Antigenic Cartography
Influenza antigenic cartography (Figure 2.3) by Smith et .al., a two dimensional rep-
resentation of the antigenic distance between strains that shows the antigenic variation
of the virus across time. This computational technique is also used to help in seasonal
influenza vaccine strain selection [59, 60, 61, 62, 16]. The influenza antigenic map pro-
duced by Smith et. al.,[16] was based on the multidimensional scaling (MDS) method
published in [63]. In [63], the authors provided methods related to related to metric
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and ordinal multidimensional scaling algorithms first developed in the mathematical
psychology literature, to construct explicit, quantitative coordinates for points in two
dimensional space given experimental data such as hemagglutination inhibition assays,
or other general affinity assays. The points are the antigens and antibodies and that
the coordinates of these points in the two dimensional space represent their physico-
chemical properties related to binding. Distances between these points are assumed to
be related to their affinity, with small distances corresponding to high affinity. As long
as the experimental affinity data (antibodies to antibodies, antigens to antigens, and the
affinity of antigens to antibodies) is available from binding assays, a cartography map
can be produced. The drawbacks are that the binding assay data can contain missing
values and the resolution of the data might not be optimal. In [16], the antigenic maps or
cartography were produced based on a functional minimization approach and solved by
using conjugate gradient optimization method with multiple random restarts. Briefly,
the map is based on minimizing the function: E(Di,j , di,j) =
∑
i,j(Di,j−di,j). Dij is the
target distance between antigen i and antiserum j derived from the HI measurement
Hi,j from the binding assays. dij is the Euclidean distance between the coordinates of
antigen i and antiserum j in the antigenic map. Basically, MDS tries to minimize the
difference between the Euclidean distances of all embedded antigen and antiserum pairs
in the map and the corresponding HI values [64]. Antigenic map/cartography can also
be produced by a linear algebra approach in which we seek the eigenvectors of a sym-
metric pairwise distance matrix. This pairwise distance matrix can be computed from
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the Di,j matrix using any distance functions. The most common distance measure is
the Euclidean distance function di,j =
√∑p
1(x
i
p − x
j
p)2 where xi and xj are two vectors
in p dimensions. The results produced by MDS using Euclidean distance measure is
the same as Principal Component Analysis (PCA). However, MDS has the flexibility to
use difference distance function besides the Euclidean distance function, for example,
city-block distance or Mahalanobis distance.
Cai et. al.,[53] developed a computational framework to construct cartography for
influenza virus using Singular Value Decomposition (SVD) technique. Their approach
utilized SVD method to generate the lower dimensional representation of the datasets
and plotting the results on a two dimensional graph. The rationale is that because HI
binding data tends to be noisy and often with missing entries in the dataset, a lower
representation that can capture the essential signal from the full dataset is usually
sufficient for general purpose visualization of the evolutionary trend of the influenza
virus.
2.7 Influenza Virus Evolution and Vaccine
Research studies that focus on how vaccination affecting the evolution of influenza virus
have been few and scarce. In this section, we will present research studies that have
investigated the effects of vaccination have on the evolution of influenza viruses. Al-
though these studies were only done on mice and chicken, but the results are very useful
in understanding the evolution of influenza virus from a different point of view. Hensley
31
Figure 2.3: Antigenic map or influenza cartography. Generated using Hemagglutinin
Inhibition binding data of seasonal A/H3N2 virus. The vertical and horizontal axes
both represent antigenic distance and the orientation of the map is free. The spacing
between the grid lines is 1 unit of antigenic distance (corresponding to a 2 fold dilution
of antiserum in the HI assay. Two units is 4 fold dilution, 3 units is 8 fold). Each clump
is designated by a location-year name on the map. The locations are in chronological
order: Hong Kong 1968, England 1972, Victoria 1975, Texas 1977, Bangkok 1979,
Sichuan 1987, Beijing 1989, 1992, Wuhan 1995, Sydney 1997 and Fujian 2002.
et. al., [65] infected mice with a seasonal influenza virus strain isolated in 1934 from
Puerto Rico (A/Puerto Rico/8/1934 H1N1). A group of mice were vaccinated against
this virus and developed antibodies against it, while another group were unvaccinated.
After the infection of the vaccinated and unvaccinated mice with the 1934 influenza
strain, the viruses were passed on to a new set of mice and this process was repeated
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nine times. After the ninth passage, sequencing results of the HA surface protein re-
vealed that the unvaccinated mice showed no mutation on the HA protein. In contrast,
the HA gene in virus isolated from vaccinated mice had mutated. The mutation helped
the virus to become more adherent to the receptors of the host cells. The mutated virus
essentially developed a way to shield its hemagglutinin antigenic sites from antibody
attack. In the second set of experiments, they infected a new set of unvaccinated mice
with the mutant virus emerged in the first series of experiments. Due to the lack of
vaccine pressure in these mice, the virus reverted to a ’low-affinity’ form. Their results
suggested that influenza virus ’reacted’ differently to their environment and that vaccine
pressure played a significant role in how the virus evolved in a vaccinated environment.
Studies [45, 4] to understand vaccine pressure on the evolution of the influenza
virus using phylogenetic analysis have been performed on avian influenza H5 subtype
viruses isolated in a Mexico chicken farm. Extended vaccination program was used in
Mexico check farms in the early 1990’s to mid 2000’s and significant antigenic drift of
avian influenza viruses has been observed in chickens. Isolates from years 2002-2006
show significant genetic drifts when compared with the vaccine strain. The studies
also demonstrated that genetic drifts in the HA gene lineages followed a yearly trend,
suggesting gradually cumulative sequence mutations. After vaccine introduction in 1992,
multiple sublineages separated from vaccine lineage were detected which suggesting the
virus has mutated away from vaccine strain. Continual genetic and antigenic drifts in
avian influenza virus have not been detected before and are occurring after the vaccine
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introduction in Mexican chickens. These findings suggested that antigenic drift and
mutations are likely aided by homologous challenge strains alone.
2.8 Phylogenetic Analysis
Phylogenetic tree construction has always been the universally accepted method of
studying the evolution of influenza viruses. Although we did not use this method in
our study, a brief introduction would help readers to at least make aware of the utility
of this widely used approach. Phylogenetic analysis of influenza viruses is essentially
a two dimensional representation of the evolutionary relationships of the viruses with
underlying assumptions about the evolution process applied in the analysis. Unlike our
approach, we do not assume any evolutionary process before the analysis and hypotheses
are only generated after seeing the results from the analysis.
2.8.1 Phylogenetic tree construction
In this section, we provide a brief introduction to phylogenetic tree construction. Phylo-
genetic tree provides the means to display the evolutionary relationships among species,
genes, genomes, or any other entities that share a common ancestor, in a two dimen-
sional graphical format [66]. To represent the relationships from a common ancestor to
its descendants, phylogenetic tree construction algorithms build branching patterns with
branch length that capture the ’changes’ along their imputed evolutionary paths. One
must bear in mind that the branching patterns that make up a phylogenetic tree can
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rarely be observed directly [66]. Three widely used methods of phylogenetic tree con-
struction are: (1) parsimony, (2) distance based, and (3) maximum likelihood method.
Within all these methods, a scoring function is used to score all the possible trees to find
the best tree that can arise from the data. In general, what is estimated by phylogenetic
tree construction is the amount of evolutionary change between the inner nodes and the
leaves of the tree [67]. Phylogenetic studies of the evolution of influenza viruses are
mostly performed using the distance based and the maximum likelihood methods. This
is because these two methods give more reliable results or predictions when analyzing
viruses that are isolated across a long time period and that the variation of evolutionary
rate can be taken into account.
2.8.2 Methods
In this section, we briefly describe each phylogenetic tree construction method currently
being used in the field of molecular evolution studies.
Parsimony method
Simply put, the parsimony method is based on the idea that the best tree or branching
pattern is the one that requires the fewest evolutionary changes to capture the complete
evolutionary relationships between the ancestor and its descendants. Given an aligned
sequence dataset, this method computes all the scores for all the possible branching
patterns that can be generated based on the ”simplest is the best idea” from the dataset.
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The score is a measure of the number of evolutionary changes or substitutions that
would be required from the ancestor to its descendants. The tree that has the lowest
score is considered the most likely representation of the true evolutionary history of the
sequences in the dataset. This tree is also called the most parsimonious tree. A major
drawback of this method is that the number of possible trees increases exponentially
as the number of sequences grows. This is a serious drawback by today’s standard as
next generation sequencing technology can easily generate over millions of sequences.
The amount of sequence data that is available for analysis makes this method the least
attractive among the three. One way to get around this limitation is to only score the
shortest tree and not all the possible trees. To do this, heuristic search is implemented
in the algorithm to search through the large tree space to find the shortest tree. In
general, parsimony method works well with small number of sequences with strong
sequence similarity and can produce reliable results. But as the number of sequences
grows, the amount of memory and computational time required can become a significant
factor that affect the accuracy of the results. This is because the heuristic search engine
used in the algorithm can be trapped in a local minima in the tree space.
Distance based method
The main idea behind the distance based method is to infer evolutionary relationships
from the patterns of similarity among organisms [66]. Given a sequence dataset, a dis-
tance matrix is generated by computing the pairwise distance between the sequences.
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This distance matrix reflects the similarity among all the sequences in terms of changes
observed from the data. However, one needs to adjust the distance matrix to correct it
to account for the evolutionary events (single substitution, multiple substitutions, coin-
cidental substitutions, parallel substitutions, convergent substitution, and back substi-
tution) based on some pre-defined Markov model that describes the probabilities of each
nucleotide change. For example, the Jukes-Cantor Markov model [67] is a commonly
used model that can be applied for distance matrix adjustment or correction. Once
the distance matrix is corrected, a phylogenetic tree is then constructed based on the
distance values of this matrix. Two popular distance based phylogenetic methods are
in use today for studying influenza virus. One, the UPGMA (unweighted pair group
method with arithmetic mean) method. Two, the neighbor-joining method. UPGMA
method assumes the rate of change along the branches is a constant and that the dis-
tances are approximately ultrametric, meaning that for three sequences (a,b, and c),
Dac ≤ max(Dab, Dac) where D is the distance measure [67] between two sequences.
The constant evolutionary rate assumption implies that all of the leaves in a tree are
equidistant from the root of the tree.
The neighbor-joining (NJ) method is widely used in phylogenetic analysis of in-
fluenza virus because it allows for evolutionary rate variation on separate branches of
the tree. This is especially suitable to analyze difference subtypes of the influenza virus.
The NJ method works by first forming the corrected distance matrix, then join the two
sequences that give the smallest distance value. This pair is then become a new ’entity’
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and the distance matrix is recomputed based on this new entity. This step is repeated
until all the entities are joined to form the phylogenetic tree.
Maximum likelihood method
Likelihood and Bayesian methods have been designed to provide a statistical framework
for phylogenetic reconstruction [66] but at the expense of computational time. This
method is computationally intensive because it considers all possible trees to find the
best probable tree that fits the data best. The likelihood score L of a tree is written
as L = Prob(D|Tree) where Tree are all the possible trees and D is the dataset given.
Maximum likelihood method requires an evolutionary model (e.g. Jukes-Cantor or
Kimura model) that estimates the rates of substitution of one base for another in a set
of sequence data. Once the model is selected, the probability that the sequence data
would be generated given a particular tree can be computed. The best tree is found as
the one that has the highest probability of producing the observed sequence data based
on the model selected.
2.8.3 Challenges
All phylogenetic tree construction methods will generate a tree or some trees, the is-
sue is then how well does the constructed tree represent the underlying evolutionary
relationships of the given data. Approaches for determining how well a particular tree
represents the data have been proposed because of this issue. One such approach is the
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bootstrapping approach. This approach resample the data repeatedly and reconstruct
the phylogenetic tree to see how often the same result is obtained from the resampled
dataset. If resampling the data without replacement, it is called the jackknifing tech-
nique. Another approach is to compare the trees generated with different methods and
determine how similar they are to each other. One can compare parts of the tree with
each other and score the number of differences in tree branching.
The success of phylogenetic analysis depends on the multiple sequence alignment
algorithm that is applied to the data before trees are constructed. For sequences that
have diverged considerably, it is a difficult issues because the multiple sequence align-
ment may not be optimal and can affect the reliability and topology of the constructed
trees[67]. This raises the issue of how to choose a suitable multiple sequence alignment
method for the data at hand before the phylogenetic analysis. If the sequences are
closely related and there are no gaps or insertion/deletion in the sequence data, then
any good multiple sequence alignment algorithms that emphasize on local or global
alignment score can be used. If the sequences have high degree of variation, then a
global alignment scheme might be more suitable.
Another aspect of challenge in phylogenetic trees construction is that inferring an-
cestry lineage with limited data can cause bias in interpretating of the result. The origin
of the recent 2009 swine H1N1 pandemic outbreak was first inferred by using phyloge-
netic tree approach with swine influenza sequences which led to the conclusion of the
origin of the A/H1N1pdm09 being a swine originated influenza virus [68] based on the
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topology of the tree. However, further study by [69] concluded that the A/H1N1pdm09
strain actually came from a human source.
Phylogenetic tree construction or analysis is very useful to elucidate the genetic
origins, selection pressures, evolution rates, reassortment histories, and population dy-
namics of influenza viruses in different host population. Given the rapid increase of the
viral sequence data, this important tool faces the challenge of large computational costs
that potentially limits its success in producing accurate and robust results.
Chapter 3
Novel Markov Model
3.1 Introduction
In this chapter, we present a compact Markov model that models the evolution of the
influenza virus as a sequence of single point mutations, using a two-layered statistical
model: a Markov chain for the mutations and a Poisson process for the timing of their
occurrence. Modelling the mutations this way captures much of the process because
the fixed length of the influenza genome segments mean very few insertions or deletions
occur. This model allows us to estimate the probabilities of seeing similar influenza
viruses after long time gap. Our working hypothesis is that after a long enough time
gap, many site mutations should accumulate in the virus due to a lack of a proofreading
function [70], leading to distinct modern variants. Our working assumption is based
on the neutral theory of evolution [71] and that each amino acid or nucleotide site is
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under a neutral mutation process. We test our hypothesis by combining a standard
Poisson process with the Markov model. The Poisson process models the occurrences
of mutations in a given time interval, and the Markov model estimates the probabilities
of changes to the genetic distances due to mutations. We show that it is highly unlikely
that very similar sequences would arise long after the original sequence. Given the
observations of several pairs of very similar sequences separated by several decades, our
results suggest that there must be some reservoir or evolutionary mechanism that is
capable of preserving old virus strains, allowing them to reappear after extended time
intervals.
3.2 Compact Markov Model
We model all mutations as the combination of several single point mutations and use a
Poisson process to model the mutation rate. The Poisson process naturally admits more
complex mutations, treating them as several single point mutations occurring in rapid
succession. Then we build a compact Markov model to model the mutations themselves.
Markov models have proven to be a powerful tool for phylogenetic inference and hy-
pothesis testing when modeling transitions between amino acid states. Modeling amino
acid transitions is complex since proteins are made of twenty amino acids. Because of
this, we take a very different approach in building our Markov model. We are trying
to avoid a Markov chain where each sequence is a state because this would give rise
to an exponentially large number of states (20n where n is the number of sites). In
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our Markov model, we collect into a single state Hk all the protein sequences at given
Hamming distance k from a given starting sequence s0 ∈ H0. The starting sequence
s0 can be chosen either as the earliest isolated sequence or the most recent one. Our
Markov model assigns the probability of an arbitrary HA sequence s1 ∈ Hk mutating
into a different HA sequence s2 ∈ Hl through a single point mutation, where l must be
one of k − 1, k, k + 1.
Previous studies [72, 73] have shown that to better fit the model, conserved sites
should be excluded in the analysis under the neutral theory framework. Here we have
taken the same approach where we have limited the mutations captured by our Markov
chain to the HA1 domain consisting of n = 329 sites, since this region is less conserved
than the HA2 region [74, 75]. Therefore, our Markov model has only n+1 = 330 states
instead of the 20n states it would have if we kept each state and each possible transition
separate.
Formally, consider a finite set of states labeled {H0, ..., Hn}. In order to keep the
Markov chain to a manageable size, we group all the sequences within Hamming distance
of k from a start sequence into a single “super state” Hk. At each transition, we
assume a single point mutation occurs, and that this mutation of amino acid replacement
exhibits uniform rate of evolution throughout long periods of evolutionary time [76].
This assumption is particularly consistent with the concept of ”molecular evolutionary
clock” and is central to the neutral theory [77, 78, 79]. Because of the high rate at
which RNA viruses evolve, it has been observed that these sequences show the typical
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pattern of neutral evolution [78].
We denote by a the size of the alphabet of amino acids, in our case 20. For a
sequence s1 ∈ Hk, there is a probability k/n that the mutation occurs in one of the k
positions where s1 differs from s0, and if this change occurs, there is a 1/(a− 1) chance
that the new amino acid in this position will match that in the same position of s0.
Hence the probability xk of a transition from Hk to Hk−1 is xk =
k
n
· 1
a−1 . Similar
reasoning yields the probability yk that a transition will remain at the same Hamming
distance: yk =
k
n
· a−2
a−1 . The probability that a mutation will be in one of the n − k
sites that still match s0 is zk = 1−
k
n
, corresponding to a transition from Hk to Hk+1.
The resulting probabilities xk, yk, zk are assembled into a Markov transition matrix M
as shown below. The entries in each row of M add up to 1.


0 1
x1 y1 z1
. . .
. . .
. . .
. . .
0 xn−1 yn−1 zn−1
xn yn


=
1
n


0 n
1
a−1
a−2
a−1 n− 1
. . .
. . .
. . .
. . .
0 n−1
a−1 n− 1
a−2
a−1
1
n
1
a−1
a−2
a−1


Using this model, we can compute the probability qt that a virus will have a Ham-
ming distance at most κ from the initial source sequence after t mutations. We give the
general form of how to compute the above probability. We let vt = (vt0, vt1, . . . , vtn)
be the row vector of probabilities of being in state H0, H1, . . . , Hn, respectively, after t
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mutations. At t = 0 we are in state H0 consisting of just the initial sequence. This is
represented by the row vector v0 = (1, 0, 0, ..., 0). Then the vector of probabilities after
t+ 1 mutations is related to the probabilities after t mutations by vt+1 = vt ∗M . The
probability of being at most distance κ from s0 after t mutations is the sum of the first
k + 1 components of vt: qt(k) =
∑k
i=0 vti.
The above analysis counts events consisting of a single mutation. The mutation rate
is modeled by a Poisson process [80, 81]. This includes the possibility that no mutation
or several mutations take place in a given time interval, assuming all sites undergo the
same substitution rate. This assumes that the probability of a mutation in a given time
interval depends only on the length of the interval but is independent of the behavior
outside the time interval. If λ is the average number of mutations in a time interval of 1
year, then the probability that t mutations occur in any time interval of length Y years
is given by pt(Y ) =
(Y λ)t
t! e
−Y λ. The Poisson process models when mutations occur, and
the Markov model models the nature of the mutations. Combining these two models
yields the probability Pκ(Y ) that after Y years a sequence would appear with a genetic
distance κ from s0 of κ, namely Pκ(Y ) =
∑∞
t=0 pt(Y ) · qt(κ).
3.3 Hemagglutinin Sequence Data
The HA protein is the major surface antigen of the influenza virus. Its role is to bind to
host cell receptors promoting fusion between the virion envelope and the host cell [82].
Influenza A virus HA genes have been classified into 16 subtypes (H1-H16) according to
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their antigenic properties. This HA protein is cleaved into two peptide chains HA1 and
HA2 respectively when matured [22]. The HA2 chain has been found to vary less and is
more conserved compared to HA1 chain [83]. The HA1 chain is 329 residues long and is
the immunogenic part of HA protein. Past studies have shown that HA1 is undergoing
continual diversifying change [72, 75] and is the most variable portion of the influenza
genome[84].
Using the NCBI Influenza database available online, we have collected 3439 influenza
virus type A protein sequences deposited before December, 2007 (excluding identical
sequences and lab strains/NIAID FLU project). This collection of protein sequences
contains isolates from around the globe and from a diverse range of hosts. We used
protein sequences because they were known to give more reliable results than nucleotide
sequences when constructing evolutionary history [22]. Each of the 3439 sequences has
a unique annotation which contains the host organism, the strain number, the year of
isolation, subtype, and protein name. We aligned all sequences to a consensus sequence
using the NCBI alignment tool. According to the study presented by [84], a uniform
consensus strain tends to circulate for some time, since the mutations that occur during
replication do not become fixed in the early stages of circulating. The aligned sequence
data were then used with a genetic distance function to determine the pairwise genetic
distance (including gaps) of the sequences.
The genetic distance between two sequences can be thought of as the edit distance,
which is the number of single letter changes needed to transform one sequence to the
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other. This yields a simple scoring function assigning a zero to a matching amino
acid base and a one to a mismatch. The sum of all mismatches is usually called the
Hamming distance (k) or Hamming score for the pairwise sequence comparison. For
comparison of very similar biological sequences, this Hamming distance can be used
under the assumption that the observed difference between a pair of sites represents
one mutation [85]. The present study could also be carried out using BLAST or any
alignment algorithm, but as considerably greater expense. In [74], Hamming distance
was successfully used to find interesting clusters of IV HA sequences and to predict
vaccine strains with good results. Hamming distance as genetic distance between viruses
has also been used effectively in modeling influenza viruses [86]. In our study, we
compute the Hamming distance based on a consensus alignment to account for the small
number of insertions and deletions. We then store the pairwise Hamming distance scores
of HA gene in a pairwise affinity matrix and identify virus sequence pairs sharing high
sequence similarity (at least 90 percent) but separated by a long time gap.
3.4 Results
Strain H Y EG P-value
AAD17229: A/South
Carolina/1/1918 0 0 0
source
sequence
AAA91616: A/swine/St-
Hyacinthe/148/1990(H1N1) 20 72 47.3 6.3499e-06
Table 3.1: H1N1 subtype long time gap strains (Rate: 2×10−3 per site per year). H =
Hamming distance, Y = Year, EG = Expected number of mutations.
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Figure 3.1: Seasonal human influenza H1N1 virus pairwise Hamming distance computed
using the oldest strain (A/North Carolina/1918) as the source to every other isolates in
the dataset. Toward year 2000’s, most of the H1N1 have evolved away from the source
strain.
We first identified viruses having very close genetic distance but with large time gap.
Figure 3.1 shows the H1 subtype HA1 domain pairwise sequence genetic distance plotted
against time of isolation in year. The genetic distance corresponds to the Hamming dis-
tance including gaps. Tables 1 and 2 show viruses sharing very high sequence similarity
but with large time gap. We used the amino acid substitution rate of r = 2×10−3 per site
per year for H1 and H2 subtype viruses, estimated using the entire region of the HA gene
and assuming that the molecular clock is followed [22] throughout evolutionary history.
This yields an annual mutation rate of λ = nr = 329·2×10−3 = 0.658. We give two exam-
ples of unlikely similarities over long time gaps in table 3.1 and 3.4. Each table includes
the accession number “Accession”, strain name “Strain”, the Hamming distance “H”
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Strain H Y EG P-value
AAY28987: A/Human/
Canada/720/2005(H2N2) 0 0 0
source
sequence
AAA64365: A/RI/5+/
1957(H2N2) 6 48 31.5 7.807e-09
AAA64363: A/RI/5-/
1957(H2N2) 3 48 31.5 1.206e-11
AAA64366: A/Singapore
/1/1957(H2N2) 5 48 31.5 1.155e-09
AAA43185:A/Human/
Japan/305/1957(H2N2) 5 48 31.5 1.155e-09
Table 3.2: H2 subtype long time gap strains
(calculated from the first strain), expected number of mutations “EG”, the year differ-
ence “Y”, and the P-value, the probability that this Hamming distance (or less) would
be observed after the given time interval as predicted by our model. Using the pandemic
strain A/South Carolina/1/1918 and A/swine/St-Hyacinthe/148/1990(H1N1) from Ta-
ble 3.1, the interpretation of the result is that after 72 years, the expected number of mu-
tations is 47.3 and the probability of being within a Hamming distance of 20 of the origi-
nal source sequence is 6.35×10−6. A very recent published research study [79] employing
the state-of-the-art Bayesian Markov chain Monte Carlo [87] which allows for substitu-
tion rate variation and maximum likelihood phylogenetic methods indicates that this
A/swine/St-Hyacinthe/148/1990(H1N1) virus is a contaminant from the A/swine/1930
strain. The genetic distance of the pandemic strain to the A/swine/1930 strain is
22. The genetic distance of A/swine/1930 to A/swine/St-Hyacinthe/148/1990(H1N1) is
only 3 indicating that these two strains are virtually identical. From table 2, we see that
A/Human/Canada/720/2005(H2N2) strain isolated in 2005 is exceptionally similar to
the two asian pandemic strains A/Singapore/1/1957(H2N2) and A/Human/Japan/305/
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1957(H2N2) in terms of the genetic distance. These two pandemic strains were human
transmissible and currently no influenza vaccines contained the H2N2 virus [88]. This
reappearance of the highly pathogenic H2N2 virus could cause a potential pandemic
as current population is not immunized against this strain of virus. The origin of the
A/Human/Canada/720/2005(H2N2) strain was traced back to human error at a labo-
ratory distributing virus samples for training purposes and the distributed strains were
quickly destroyed at all receiving laboratories [88].
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Figure 3.2: Poisson process distribution plot
To check how our model matches the data, we show the predicted distribution of
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Figure 3.3: H2 subtype histogram plot
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Hamming distances in Figure 3.2 based on a time interval of Y = 49 and annual mutation
rate of nr = 0.658 for the H2 subtype. The peak of the curve indicates that with high
probability, roughly 30-40 mutation events would have taken place. This tells us that
we should expect to see the majority of H2 sequence pairs with Hamming distances
in the vicinity of 40 given the length of time interval equals 49 years base on Poisson
process assumption. We compare this to the actual distribution of Hamming distances
found in the H2 subtype data shown in Figure 3.3 over the range of data available (from
1957 through 2006 or a span of 49 years). Figure 3.3 shows that the majority of the H2
sequence pairs have Hamming distances around 35, which matches the Poisson process
prediction. Figure 3.5 illustrates how the probability values of 3 H2 strains in Table
3.2 are rapidly dropping against the expected number of mutations from the Markov
model calculation. Figure 3.4 shows the predicted distribution within the time interval
of 70-85 years from the combined Poisson process and Markov chain model using H1
subtype HA1 sequences. The curve shows that with high probability most sequences
should be in states H60 to H70. This reflects what is observed in figure 3.1 and figure
3.6 where most sequences have Hamming distance around 60-70. This suggests that
our model is able to capture the overall evolutionary behavior of the influenza virus
according to a molecular clock, leading to a natural increase in the genetic distance as
time passes, consistent with [77].
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Figure 3.5: H2 strains probability plot
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Figure 3.6: Histogram of H1 from 1996-2006
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3.5 Conclusions
The extensive genetic diversity of influenza A viruses through genetic drift and reassort-
ment in the past century has resulted in many new strains being produced. However,
H1, H2, and H3 subtypes strains have displayed cyclic behavior resulting in influenza
pandemics [89]. In the present study, we applied neutral evolution theory to influenza
virus HA protein sequences to investigate the evolutionary dynamics of the virus. We did
not include the other mutational changes (compensatory and transition/transversion)
as our aim is to model the influenza strictly under a neutral evolution process. The
model can be extended to include other types of mutational changes but it will require
to model each site individually. Using the combination of a Poisson model with a novel
Markov model, we were able to calculate the probability values of finding a very similar
sequence composition separated by a large time gap. We have so far been able to identify
several anomalies due to laboratory artifacts or human error. This finding is promising
since we have yet to apply it in a full scale comprehensive analysis of all 16 subtypes of
the virus. However, judging by the extremely low probability values obtained for some
observed sample strains, we conclude that there may be one or more sources of various
strains of the virus in which they are preserved over long time periods. The existence
of reservoirs preserving viruses for decades cannot be completely eliminated.
Chapter 4
Influenza Evolution Analysis with
Binary Encoding Approach
4.1 Introduction
In this chapter, we present the computational approach that is used to study the evo-
lution of influenza viruses. This approach is based on encoding nucleotides and amino
acids using a fixed length binary code. The application of this approach to difference
influenza virus datasets is presented in this chapter and subsequent chapters in this
thesis.
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4.2 Background
The rapid growth of the influenza genome sequence data due to the advanced develop-
ment of sequencing technology in recent years has provided the opportunity for a more
comprehensive sequence analysis of the influenza virus. The difficulty in sieving through
and making sense of this mountain of data relying solely on phylogenetic approaches has
become increasingly limited in part due to the poor scalability of the relevant algorithms
[90, 81, 91, 92, 93, 94]. Therefore, a different methodology needs to be utilized in order
to take advantage of the massive amount of available data but at the same time be able
to expose important information or structure that can help to generate new hypothesis.
In this chapter, we present an application paradigm in which an unsupervised machine
learning approach is applied to the high dimensional influenza genetic sequences so that
the evolution of the influenza virus in the past century can be visualized. The unsuper-
vised machine learning approach consists of three steps: (1) genetic sequence conversion
by binary encoding, (2) dimensional reduction and scatter matrix computation, and (3)
visualization. Genetic sequence conversion is a data preprocessing step where biological
sequence data is converted into numerical values for analysis. Dimensional reduction
is carried out by the unsupervised machine learning method called Principal Compo-
nent Analysis (PCA). The results from PCA are directly used in the scatter matrix
computation in order to quantify the evolution paths of the influenza virus. The final
visualization step is the visualization of the projected data on the leading components of
the PCA. This step offers us insight and alternative perspective into this rapid evolving
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antigen in difference hosts and environments.
4.3 Genetic Sequence Conversion
For nucleotide sequences, we encode Adenine (A) to ”0001”, Guanine (G) to ”0100”,
Cytosine (C) to ”0010” and Thymine (T) to ”0001” [95, 96]. Each nucleotide base is
uniquely represented by a 4 digits binary string. For example, to encode a nucleotide
sequence of ”AGA” and another of ”ACA”, AGA is transformed to 0 0 0 1 0 1 0 0 0
0 0 1 and ACA is transformed to 0 0 0 1 0 0 1 0 0 0 0 1. When these two sequences
are compared, the mutation in the second position is captured by the different between
0100 and 0010. This encoding scheme allows for direct capture of mutation information
between sequences and facilitate direct subsequent computational analysis. For protein
sequences, we convert each amino acid to a binary string of length twenty and each
string is different by only one bit. For example, Alanine is coded as ”1 0 0 0...0 0 0” and
Cysteine is coded as ”0100...000”. In addition, the biophysical properties data of each
amino acid can be directly append to the end of the twenty bits string. For example,
the hydrophobicity value of Alanine is 1.8 and the binary string of Alanine becomes ”1
0 0 0 ... 0 0 0 1.8” which further distinguishes the differences between each amino acid.
Even though the length of the nucleotide sequence has been increased by a factor of 4
and protein sequence by a factor of 20, the sparse data can be stored efficiently (low
memory requirements) and there are algorithms to process them efficiently.
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4.3.1 Incorporating amino acid biophysical information
The binary encoding scheme with the inclusion of amino acids’ biophysical properties
leads to substantially better results in distinguishing different subtype when protein
sequences are used. The biophysical property we have used in this study is the hy-
drophobicity property of amino acids. Ray [97] carried out a study to determine the
most suitable biophysical properties to use with unsupervised classifiers [97] and found
that three properties: Volume, Hydrophobicity, and Isoelectric property are best suited
for classification purposes. In our study, we have tried all three of the said properties and
found that hydrophobicity is best suited for influenza sequences. We demonstrate this
result by applying our coding scheme combined with hydrophobicity values (H-value)
on H3 and H5 subtypes genetic sequences. We obtained the hydrophobicity values for
all the amino acids published from the study conducted by Ray and Kepler [97]. After
appending each H-value to the binary string of each amino acid and converted all the
protein H3 and H5 sequences into binary strings, PCA (see 4.4.2) was used to provide
visualization (Figure 4.1 and Figure 4.2) between the two subtypes on two dimensional
plane. For comparison purpose, we produced a projection of H3 and H5 sequence with-
out using the H-value, as shown in Figure 4.1. Although we see data separation in both
cases, the projection result with H-value applied clearly explained more variance (at 70
percent) than the one without (at upper 30 percent). The separation between H3 and
H5 also has become more pronounced with less overlapping strains from each subtype.
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Figure 4.1: Top: PCA projection of H5N1 (red) and H3N2 (blue) protein sequences
without applying hydrophobicity information. Bottom: The variance captured by the
projection method without applying hydrophobicity information.
4.4 Principal Component Analysis
The dimension reduction step mentioned in section 4.1 is performed by using Principal
Component Analysis. Principal Component Analysis (PCA) was described in [98, 99]
as finding ”the best fitting straight line to a points coincides in direction with the max-
imum axis of the correlation”. It is quite ’old’ [100] but remains one of the most used
techniques today in data analysis. PCA is a statistical analytical tool that is widely
used in data exploration and pattern recognition. The general idea of PCA is that it
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Figure 4.2: PCA projection of H3 (blue) and H5 (red) protein sequences with hydropho-
bicity information incorporated.
transforms large number of correlated variables into a smaller number of uncorrelated
variables while retaining maximal amount of variation. This transformation process
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can identify patterns in data that highlight their similarities and differences, thus mak-
ing PCA a very powerful tool in data analysis. PCA has been used extensively for
dimensional reduction in analyzing high dimensional dataset. [52, 101, 102, 103]. The
dimension reduction is a linear projection technique that projects high dimensional in-
put vectors into low dimensional ones whose components are uncorrelated [104, 105].
The linearity refers to the (1) change of basis when performing projection as the new
basis are linear independent of each other and (2) the ’new’ variables (PC’s) are the
linear combination of the original variables. This projection is a global orthogonal pro-
jection on the complete dataset. PCA can also be viewed as an unsupervised machine
learning method because it ignores all the data labels and only relies on the attributes
of the data. The objective of PCA is to minimize loss of information in the data while
representing each data sample with a reduced set of attribute values. When applying
PCA to analyze a dataset, it is often possible to capture a large percentage of the
total variance with only a few principal components. This is because each principal
component captures the maximum proportion of the total variance successively.
4.4.1 Limitations of PCA
Principal Component Analysis has its limitations [106] and these limitations are not
restricted to specific data being analyzed using PCA. The limitations can be outlined
as follows:
• The interpretation of each principal component (PC’s) is very difficult. This is
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because each PC is a linear combination of the original variables.
• PCA only performs orthogonal transformations of the original variables. Some
data might require a nonlinear transformation or mappings in order to reveal
special structure in the data.
• The directions with largest variance are assumed to be of most interest.
• If the original variables were uncorrelated, PCA can only order them according to
their variance.
• Discarded PCs are not always ’useless’ and it is not clear on how many PCs to
retain/discard when performing dimension reduction. For visualization purposes,
the leading two or three PCs are used.
• PCA can be sensitive to outliers since it is based on the sample covariance matrix
which is sensitive to outliers.
• PCA is not scale invariant as eigenvectors are not scale invariant.
• When all measurements are positively correlated, the first principal component is
often some kind of average of the measurements [106].
4.4.2 Application of PCA to Influenza Data
Principal Component Analysis (PCA) is used in all forms of analysis from gene expres-
sion data analysis [107, 108, 109] to computer vision. It is a simple non-parametric
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method of extracting relevant information from unstructured data sets. The extraction
can be viewed as dimensional reduction where a complex high dimension data set is re-
duced to a lower dimension in order to reveal hidden, simplified structure buried within
the data. In order to find the best lower dimension to capture the structure of the high
dimensional data, PCA proceeds by diagonalizing the covariance matrix of the data set,
consistent with the goal to maximize the variance captured in the projected data onto
the lower dimensions. One property is that PCA requires the directions of projection be
orthogonal to each other and the variance associated with each direction be maximized.
The orthogonal requirement makes PCA solvable with highly efficient linear algebra
decomposition techniques. Here, we introduce the working mechanic of PCA from a
linear algebra perspective. Consider a data matrix Xm,n with dimensions of m by n
with m being the number of strains and n being the number of sites. Each row of X
corresponds to a strain of virus and each column of X corresponds to a particular site.
We first need to center the rows of the data matrix X (i.e. replace X with X− 1
m
eeTX,
where e is a column vector of all ones) and then obtain the covariance matrix C from
X by C = 1(m−1)X
TX. C is a square symmetric m×m matrix whose diagonal entries
are the variances of the individual strains across sites and the off-diagonal terms are the
covariances between different strains. If one wishes to reduce the row dimensions, one
can simply apply this entire computation to the transpose of the data matrix. The goal
of PCA is to find a set of orthonormal axes that diagonalizes matrix C. The diagonal-
ization of C is computed by finding its eigenvectors. Since C is symmetric and square,
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its eigenvectors are the orthonormal principal directions, and its eigenvalues correspond
to the variances of the data along those principal directions. The eigenvectors of C
are now the new basis for the data X. The projection of the data matrix X onto this
new basis gives the alternative ”PCA view” of the data with mean zero and variance
maximized along each principal component direction. A quick decomposition technique
to obtain the orthonormal basis is using the Singular Value Decomposition (SVD), see
4.4.3 and 4.4.4. One can center the matrix, calculate the C matrix, and then applying
SVD to C. SVD of C gives C = UΣV T where the matrix V contains the orthonormal
basis we sought. We can project the data to the new basis with X ∗ V ; The matrix Σ
is a diagonal matrix that contains the eigenvalues of C which are the variances of the
orthonormal basis/principal components.
Once the transformation is made,we the select the leading two or three components
for visualization of the genetic sequence data. In order to better understand the distance
relationship as each strain is encoded as a binary string and PCA works at the binary
data level, the pairwise distance relationship between the strains in a reduced space
can be understood as follows: Let ‖s − t‖H denote the pairwise Hamming distance
between two strains s, t (number of differences in genetic sequences). Let ‖s − t‖bin 1,
‖s − t‖bin 2 denote the distance between the binary encodings of the two sequences (1-
norm and 2-norm, respectively), and let ‖s− t‖proj denote the 2-norm distance in lower
dimensional space after projection onto the leading principal components. Every single
change in the genetic sequence alphabet corresponds to changes to 2 bits in the binary
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encoding. Hence we have the relation between the distance in the lower dimensional
space shown on the plots with the Hamming distance among the original sequences:
‖s− t‖2proj ≤ ‖s− t‖
2
bin 2 = ‖s− t‖bin 1 = 2‖s− t‖H .
To illustrate this distance relationship, we computed the pairwise distance of the
oldest strain (A/Hong Kong/68 1968) to every other strains in the A/H3N2 dataset
in both the reduced PCA 2 dimensional space and in full sequence space (Figure 4.3
and Figure 4.4). The pairwise distance in the reduced 2 dimensional space is in high
agreement with the pairwise distance computed in full sequence space as indicated by
the Pearson correlation coefficient of 0.9792.
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Figure 4.3: Pairwise distance comparison of influenza A/H3N2 virus in PCA 2 di-
mensional space and full sequence space. The pairwise distance is measured using the
oldest strain (A/Hong Kong/68 1968) as the source to every other strains in the dataset.
X-axis represents A/H3N2 strains and y-axis represents distance values.
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Figure 4.4: Pairwise distance comparison of influenza A/H3N2 virus in PCA 2 dimen-
sional space and full sequence space. X-axis represents Hamming distance and y-axis
represents PCA 2D space distance value. Pairwise distance is measured by using the old-
est strain (A/Hong Kong/68 1968) as the source to every other strains in the dataset.
The correlation coefficient between the pairwise Hamming distance and the pairwise
PCA 2D distance is 0.9792.
4.4.3 Singular Value Decomposition
Given A ∈ Rm×n, in rank k, a singular value decomposition (SVD) of A (Figure 4.25)
is a factorization A = UΣV T where U ∈ Rm×m is orthogonal, V ∈ Rn×n is orthogonal,
and Σ ∈ Rm×n is diagonal. The diagonal elements in Σ must be non-negative and
ordered in decreasing order; that is σ1 ≥ σ2 ≥ σ3 · · · ≥ 0. These σ values are called
the singular values of A and the number of non-zero σ indicates the rank k of A. The
dimension of Σ is the same as A even when A is not a square matrix. The matrix U
has the left singular vectors of A and matrix V has the right singular vectors of A.
The singular decomposition of A can be computed by finding the eigenvectors of ATA
and AAT . ATA = (UΣV T )T (UΣV T ) = V ΣTUTUΣV T = V ΣTΣV T . The UTU = I
and ΣTΣ gives σ21, σ
2
2 · · · which are the eigenvalues of the symmetric matrix A
TA. The
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singular values can be found by taking the square root of σ21, σ
2
2 · · · . Next, we can
compute the eigenvector of ATA to find v′s and make them the unit vectors. The v′s
are perpendicular because eigenvectors of every symmetric matrix are perpendicular.
To construct the matrix U , a simple way is to multiply v′s by A: u1 = Av1 and make it
into unit vector and collect all the u′s into U . The arrangement of v′s and u′s should
follow the order of the eigenvalues [110, 111].
Mathematically speaking, the above mentioned method can become unstable when
it is used to compute the SVD of a matrix [112]. An alternative and stable method to
reduce the SVD to an eigenvalue problem is to first transform A to a 2m×2m hermitian
matrix H as in H =


0 AT
A 0

 and then compute its eigenvalue decomposition [112].
4.4.4 Low-Rank Approximations
The SV D approach gives an optimal low rank approximation to data matrix A [110].
The best rank one approximation to A is the matrix σ1u1v
T
1 . It is the largest singular
value σ1 and the left and right singular vectors u1 and v1. Matrix A can be represented
as a sum of rank-one matrices: A =
∑r
j σjujv
T
j . The partial sum captures as much
information of the matrix A as possible [113, 114, 115, 116, 112, 117]. In many appli-
cations, it is very useful to approximate A with a low rank matrix and the connection
with PCA is directly realized by the SVD decomposition of the symmetric covariance
matrix constructed from A. As mentioned above, the eigenvectors of AAT are simply
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the left singular vectors of A and the eigenvectors of ATA are the right singular vec-
tors of A. The SVD provides a complete approach as it gives both sets of eigenvectors
when analyzing data in terms of either rows or columns depending on applications. One
can ’zero out’ some small singular values to produce a low rank approximation of the
original data matrix. For visualization purposes, the singular values give the ’explained
variance’ of the matrix A. The explained variance is the ratio to the total amount
of variance in the projected data to that in the original [110]. In other words, it is a
comparison of the variance in the approximation to that in the original data [118]. It
can also be interpreted as
‖Aˆ‖2
F
‖A‖2
F
=
σ2
1
+···+σ2r
σ2
1
+···+σ2n
where Aˆ is the low rank approximation of
A [119].
4.5 Clumpiness measure
The ’clumpiness’ or separateness between each clusters observed in the PCA plots is
quantified by computing a class separateness value λ. The λ value is computed for all
cases (vaccinated samples and nonvaccinated samples) in order to determine the cohe-
siveness of strains within each year as observed in the vaccinated samples. Although
this clumpiness measure does not account for the directionality observed in the PCA
plots, it is a first step in quantifying the difference between vaccinated and nonvacci-
nated samples. The clumpiness measure is a two step process involving a scatter matrix
computation and a class separateness measure by simulation of class label randomiza-
tion.
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4.5.1 Multi-class scatter computation
In order to provide statistical support to the graphical results obtained, we performed
a statistical analysis based on a method that combined a multi-class scatter matrix
computation and class labels randomization. The projected data points served as the
viruses’ 2-D coordinates and the year of isolation of each virus served as the class label.
The multiclass scatter matrix involves the computation of Between-class matrix (B) and
Within-class matrix (W) (Box 1). These computed matrices were not used explicitly as
we only sought the trace of B and C. These are just the scalar scatter values: sum of
squared distances between points and their respective centers (Figure 4.5). The λo is the
ratio of trace B over trace W. A large λo indicates that the classes or clusters are well
separated between each other and that elements within a cluster are strongly related or
share the same property. This is basically an estimate on how well a multi-class Fisher’s
linear discriminant could separate the classes [120].
Figure 4.5: Class scatter visualization in PCA 2D space. Green ’x’ is the center of the
cluster. Red cluster contains viruses from year i and maroon cluster contains viruses
from year i+ 1.
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4.5.2 Class separateness measure
From the visualization results of the vaccinated samples, strains tend to cluster with the
vaccine seed strain and that each cluster contains viruses isolated within the same year.
Follow this observation, we perform a class labels (virus isolation year) randomization
in order to determine if the cohesiveness of viruses in a vaccinated sample could have
been happened by chance. Under the neutral evolution assumption, the class labels
observed could have been generated by chance since the occurrence of mutations is
random under this assumption. Once the λo is computed for all cases (vaccinated
samples and nonvaccinated samples), we randomized the class labels and recomputed
the class separateness measure value λ in order to find the probability of observing the
observed λo. This computation was carried out using the Algorithm I (Box 2). The
K1 and K2 parameters are set to 10,000 and 1000 respectively. The observed λo for
vaccinated samples was below rounding error of 10−16 which made the computation of
p-value not possible. Therefore, we resorted to reporting the distance of observed λo
from the mean D¯ in the form of D¯ + /− Dˆ.
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Box 1:
Virus isolation year as class label
C: Number of Classes
Ni number of data points in class i = 1, 2, ...C
• λ = tr(B)
tr(W )
• B : Between Class scatter matrix
–
∑C
i (ui −M)(ui −M)
T
– M = 1
c
∑C
i ui ”global mean of dataset”
• W : Within Class scatter matrix
–
∑C
i
∑Ni
j (xj − ui)(xj − ui)
T
– ui: mean of class i.
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Box 2:
Algorithm I
Let λo =
tr(Bo)
tr(Wo)
be the observed separateness value.
Repeat j = 1 : K2:
Repeat i = 1 : K1:
generate a randomization of the class labels L
compute the within-cluster scatter W
compute the ratio λi =
tr(B)
tr(W ) =
tr(T )−tr(W )
tr(W )
compute the mean µ and std σ for all λi=1,..K1
compute the distance Dj =
µ−λ0
σ
Compute the mean D¯ and std Dˆ of all Dj=1..K2
Report the distance of observed λo from the mean in the form of D¯ + /− Dˆ
4.6 Materials: influenza genetic sequence data
The human-host seasonal influenza A/H1N1, A/H3N2, influenza B virus and avian H5
(from Mexico) sequences are the vaccine controlled sample data and the avian influenza
H5 and human H5N1 sequences are the non-vaccine controlled or wild type samples in
the study. The avian H5 sequences from Mexico are from vaccinated chickens in Mexico.
The chickens were vaccinated against the avian H5 from 1994 to 2002 [45]. Table 4.1
lists the human and avian samples with year range for the viruses in each sample.
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The genetic evolution of vaccine controlled seasonal influenza virus was quantified by
distance in terms of standard deviation and visualized from their introduction into hu-
mans and compared to the genetic evolution of non-vaccine controlled influenza viruses
evolving in the wild. We used avian H5 and Human H5N1 viruses because they are
currently not being vaccinated against and can act as the ’control’ in this present study.
We included the human H5N1 virus as the ’control’ since this subtype is not currently
being vaccinated against but is under active research due to its high mortality rate in
infected humans. All influenza hemagglutinin (HA) nucleotide sequences were down-
loaded from the NCBI Influenza Database [6]. For each dataset (A/H1N1, A/H3N2,
type B, avian H5 (Mexico), and avian H5 (non-vaccine controlled) and human H5N1),
sequences with gaps or wildcard characters were removed before the analysis. The num-
ber of sequences in each dataset is listed in Table 4.1. We have focused on the HA1
domain of the HA protein because it is the most variable region of the entire HA and
this HA1 domain (987 nucleotides) also contains antibody binding sites (epitopes)[39].
Although data sample bias does exist in flu sequence databases due to curation and
lack of common agreement in sequence upload standard. The viruses selected for HA1
sequencing have been shown to be a representative subset of the total sample including
both the dominant variants circulating during the flu season and the outliers [121].
75
Table 4.1: Human and avian datasets
Samples Year Seqs
Human A/H1N1 1918-13 2140
Human A/H3N2 1968-09 175(235)
Human Type B (Vic/Yam) 1970-13 818
Human H5N1 1997-12 127(128)
Avian H5 (Mexico) 1994-02 32
Avian H5 (China) 1997-02 32
4.7 Results
In this section, we present the results by using genetic sequences alone of the vaccine
controlled seasonal human influenza A/H1N1, A/H3N2, influenza type B viruses, and
avian H5 samples and non-vaccine controlled avian influenza H5, and human H5N1 virus
samples.
4.7.1 Seasonal human influenza H3N2 virus
Seasonal influenza A/H3N2 which has the highest number of vaccine updates among the
three vaccine controlled influenza viruses, we observed that A/H3N2 viruses clustered
around vaccine seed strains chronologically since their introduction into humans in 1968
(Figure 4.6). As the time progresses, genetic distance between early strains and late
strains has been gradually increasing and the later isolated viruses appeared to have
evolved away from older strains (as shown in Figure 4.6 and Figure 4.7). In Figure
4.6, each vaccine strain is marked by an arrow along the evolutionary path. In Figure
4.7, the z-axis represents pairwise Hamming distance (in full sequence space) computed
using the oldest strain (A/Aichi/2/1968) as the source strain to every other strains in
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the dataset. The gradual genetic drift from the earliest strain to the contemporary
strains formed a ’horse shoes’ shape in the plot. One can see cluster separation between
antigenically distinct clusters across the evolutionary path. This is because each cluster
contains a vaccine strain and that each vaccine strain is used against a specific antigenic
variant of the virus. The narrow band of the evolution path also suggests that the
mutations on the HA gene are most likely concentrated on the antigenic region of the
HA protein. It is believed that the mutations within the antigenic binding regions of the
HA gene changes the shape of the HA protein in order for the virus to escape antibodies
binding. If the accumulated mutations were to occur in random positions on the HA
gene since 1968, a narrow and directionally restricted evolutionary path would not have
been captured by the PCA algorithm, rather, the PCA plot would have shown multiple
large clusters scattered within the plot. The observed evolutionary path formed by
tight chronological clusters suggests that the fast turnover of the genetic diversity of the
virus.
The Class-separateness analysis of the A/H3N2 indicated that the observed class
separateness value λo is at 30.5 which is far from the mean of the distribution generated
by using Alg I. The distance in terms of standard deviation is at 978.3± .031 as shown
in Figure 4.8. Figure 4.9 shows the ’zoom-in’ of the blue line at the left end of Figure
4.8. This distribution of λi=1...K1 is only one instant from the inner loop of Alg I. The
K1 parameter was set at 10000 and K2 was set to 1000.
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Figure 4.6: Two dimensional visualization of the evolution of seasonal human influenza
A/H3N2 virus evolution. Each arrow points to a vaccine strain (red dot) and each
vaccine strain corresponds to each vaccine update. The horizontal and vertical axes
represent the first and second principal component respectively. The color bar indicates
the isolation year of the virus from year 1968 (blue) to year 2010 (red).
4.7.2 Seasonal human Type B influenza virus
Seasonal influenza B virus was first isolated in 1940 and has diverged into two anti-
genically and genetically distinct lineages since the 1980s [122]. This virus has been
actively evolving since the divergence as seen by the number of vaccine updates (16)
since its introduction to the human population. The two lineages are represented by
the reference strains B/Victoria/2/87 and B/Yamagata/16/88 respectively [123, 124].
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Figure 4.7: A three dimensional visualization of seasonal human influenza A/H3N2
virus evolution. Z-axis represents pairwise Hamming distance (in full space) computed
using the oldest strain (A/Hong Kong/68 1968) as the source to every other strains in
the dataset. A gradual increase in the genetic distance suggests that new strains are
evolving away from the older ones as time passes.
The B/Victoria lineage predominated during the 1980s while the B/Yamagata lineage
predominated in the most part of the world during the 1990s [125]. Since then, these
two lineages have co-circulated in human population ever since. The visualization of
the evolution of Type B virus using HA gene sequences from 1970 to 2012 are shown
in Figure 4.10 and Figure 4.11 respectively. The very first observation from these two
figures is that the evolution pattern of Type B virus is very similar to the seasonal hu-
man influenza A/H3N2 virus. Specifically, there are distinct directional evolution trends
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Figure 4.8: Human A/H3N2 class label randomization simulation result. The green dot
represents the λo value (observed class separateness value). The blue line on the far left
of this figure represent the distribution of λi=1...K1.
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Figure 4.9: The ’zoom in’ of the blue line at the left end of Fig. 4.8 which shows the
distribution of λi=1...K1 from one instant of the k1 loop within the Alg I. The histogram
is generated using 100 bins.
for each lineage originating from the time when lineage split. Viruses in each lineage
gradually evolving away from the oldest strain. The chronological patterns can also be
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marked by using the vaccine seed strains as in the case of seasonal human A/H3N2
virus. In Figure 4.11, the z-axis represents pairwise Hamming distance (in full space)
computed using the oldest strain (B/Osaka/70) as the source to every other strains
in the dataset. The Yamagata lineage (red) and Victoria lineage (blue) with vaccine
updates as marked by the virus isolation year and the magenta color represents vaccine
updates before the lineage split.
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Figure 4.10: Two dimensional visualization of the seasonal Human Type B influenza
virus evolution. Two lineages Yamagata (red) and Victoria (blue) have been co-
circulating in humans since 1986. Each vaccine update is represented by the ’isola-
tion year’ of the virus from each lineage and it is marked on the evolutionary paths
for both lineages. Magenta color represents vaccine updates before the lineage split.
The horizontal and vertical axes represent the first and second principal component
respectively.
The Class-separateness analysis of the Type B influenza indicated that the observed
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Figure 4.11: Three dimensional visualization of the seasonal human Type B influenza
virus evolution. Z-axis represents pairwise Hamming distance (in full space) computed
using the oldest strain (B/Osaka/70) as the source to every other strains in the dataset.
The Yamagata lineage (red) and Victoria lineage (blue) with vaccine updates are marked
by the virus isolation year. Magenta color represents vaccine updates before the lineage
split.
class separateness value λo is at 26.3 for Victoria lineage and 25.3 for Yamagata lineage
(Figures 4.14 and 4.12). They are both far from the mean of the distribution generated
by using Alg I. The distance in terms of standard deviation is at 1310± .02 for Victoria
lineage and 1327.8± .019 for the Yamagata lineage. Figure 4.13 and Figure 4.15 shows
the ’zoom in’ of the distribution represents by the thick blue line in Figures 4.14 and
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4.12 respectively. This distribution of λi=1...K1 is only one instant from the inner loop
of Alg I. The K1 parameter was set at 10000 and K2 was set to 1000.
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Figure 4.12: Type B (Yamagata) class label randomization simulation result. The green
dot represents the λo value (observed class separateness value). The blue line on the far
left of this figure represent the distribution of λi=1...K1.
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Figure 4.13: The ’zoom in’ of the ’blue line’ at the left end of Fig.4.12 which shows the
distribution of λi=1...K1 from one instant of the k1 loop within the Alg I. Histogram is
generated using 100 bins.
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Figure 4.14: Type B (Victoria) class label randomization simulation result. The green
dot represents the λo value (observed class separateness value). The blue line on the far
left of this figure represent the distribution of λi=1...K1.
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Figure 4.15: The ’zoom in’ of the ’blue line’ at the left end of Fig.4.14 which shows the
distribution of λi=1...K1 from one instant of the k1 loop within the Alg I. Histogram is
generated using 100 bins.
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4.7.3 Seasonal human influenza A/H1N1 virus
Seasonal human influenza A/H1N1 virus has been circulating in humans since 1918 after
the Spanish flu pandemic outbreak [32, 33]. A new A/H1N1pdm09 pandemic strain ap-
peared in 2009 and subsequently began to circulate in humans and replaced the classical
A/H1N1 strain as the dominant circulating seasonal A/H1N1 subtype. The evolution
visualization of the classical A/H1N1 with A/H1N1pdm09 since its introduction to hu-
mans is presented in Figure 4.16. HA gene sequences from 1918 to 2013 were used to
produce the PCA plot. First, there is a separation between viruses before and after the
2009 pandemic. Also, the classical A/H1N1 viruses appeared to be following a narrow
directional evolutionary path. Second, the emergence of two evolutionary paths after
the 2009 pandemic can be observed. This is very similar to the Type B influenza virus
in which a lineage is split into two lineages. However, there has not been a vaccine
update since 2009 on the A/H1N1 component ever since the pandemic A/H1N1pdm09
strain overtook the classical A/H1N1 as the dominant strain. This suggests that this
emergence of separated paths observed in the figure is most likely due to the genetic
diversity within the the post-2009 strains [126]. In addition, study by Klein et al. has
shown that a fourfold increase of the mean hamming distance in the coding region of
the HA gene between strains from 2009 to 2013 [126] and a twofold increase in the
non-coding region of the HA gene. This is consistent of what is observed in the Figure
4.16 where evolutionary paths are progressively moving outward from the 2009 cluster,
suggesting the virus is actively evolving. A probable reason to support this observation
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is that the emergence of antigenic drift variants in the future is likely. Besides these
distinct observations, one can see that the evolution of A/H1N1 is similar to other sea-
sonal human influenza viruses in that there are: (1) narrow band of evolutionary paths
and (2) the newer strains are gradually evolving away from the older strains, and (3)
chronological patterns can be observed.
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Figure 4.16: Three dimensional visualization of influenza A/H1N1 evolution. The x, y,
and z axises are the 1st, 2nd, and 3rd principal components respectively.
The Class-separateness analysis of the A/H1N1 indicated that the observed class
separateness value λo is at 24.7 which is far from the mean of the distribution generated
by using Alg I. The distance in terms of standard deviation is at 617.2± .04 as shown
in Figure 4.17. Figure 4.18 shows the ’zoom in’ of the distribution represents by the
thick blue line in Figure 4.17. This distribution of λi=1...K1 is only one instant from the
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inner loop of Alg I. The K1 parameter was set at 10000 and K2 was set to 1000.
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Figure 4.17: A/H1N1 class label randomization simulation result. The green dot repre-
sents the λo value (observed class separateness value). The blue line on the far left of
this figure represent the distribution of λi=1...K1.
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Figure 4.18: The ’zoom in’ of the ’blue line’ at the left end of Fig. 4.17 which shows the
distribution of λi=1...K1 from one instant of the k1 loop within the Alg I. Histogram is
generated using 100 bins.
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4.7.4 Human influenza H5N1 virus
The sporadic infections caused by the avian H5N1 in humans has raised concern of a
potential pandemic outbreak of the H5N1 influenza virus. The avian H5N1 subtype is
thought to originated from wild bird species since its emergence in 1996 [127, 128]. Since
then, this subtype has been classified into many clades depending on its pathogenicity.
The Highly Pathogenic Avian Influenza A (HPAI) group of H5N1 can cause fatal infec-
tion in humans and the Low Pathogenic Avian Influenza Virus (LPAI) group does not
cause fatal infection. The HPAI group has been endemic in bird species and its ecology
and antigenic properties have led to a higher diver virus strains in endemic areas [129].
As of now, vaccination strategy has not been applied to fight against this subtype in
human population. Figure 4.19 presents the evolution of this virus from 1997 to 2012.
Figure 4.19 suggests that this subtype has evolved into a few dominant clusters since
1997. Three major evolutionary trends or clustering patterns can be seen originating
from the center cluster which contains viruses from 1997. This also implies this influenza
subtype has undergone HA gene diversification. Although it has diversified since 1997,
the specific H5 HA gene identified in 1997 has remained present in these days [130].
The Class-separateness analysis of the non-vaccine controlled H5N1 indicated that
the observed class separateness value λo is at 1.01 which is not far from the mean of the
distribution generated by using Alg I. The distance in terms of standard deviation is at
34.8± .029 as shown in Figure 4.20. The distribution of λi=1...K1 is from one instant of
the inner loop of Alg I. The K1 parameter was set at 10000 and K2 was set to 1000.
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Figure 4.19: Three dimensional visualization of human H5N1 influenza virus evolution.
The PC1, PC2, and PC3 represent the first, second, and third principal component
respectively.
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Figure 4.20: Human H5N1 class label randomization simulation result. The green dot
represents the λo value (observed class separateness value). The blue line on the far left
of this figure represent the distribution of λi=1...K1.
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4.7.5 Avian H5 influenza viruses
Avian influenza A viruses differ from human viruses by recognition of the receptor bind-
ing of α-2,3 sialic acid instead of the α-2,6 [131]. There are 16 HA subtypes circulating
in the avian population and that they are lesser studied then the human subtypes. The
visualization of the evolution of avian H5 is presented in Figure 4.21. The overall obser-
vation that arises from our analysis is that rather than forming a restricted directional
trend, the evolution of avian influenza virus is characterized by a collection of clusters
scattered on the PCA plot. The collection of clusters suggests a diverse pool of the ge-
netic diversity of the virus. For the avian H5 subtype, a less focused evolutionary trend
than human seasonal influenza viruses can be observed in the plots. The increased ge-
netic diversity since 2000 has been observed in [132] and is captured in Figure 4.21 with
clusters scattered to the left and extended to upper and lower corner at almost the same
time. This clearly suggests the co-circulation of multiple clades or sublineages of the
avian H5 subtype The diverse genetic diversity of the avian H5 represented by multiple
clusters across a long time period indicated that these two avian subtypes evolve much
slower than seasonal human influenza viruses.
The Class-separateness analysis of the avian H5 (non-vaccine controlled) indicated
that the observed class separateness value λo is at 0.268 which is not far from the mean
of the distribution generated by using Alg I. The distance in terms of standard deviation
is at 3.16±0.06 as shown in Figure 4.22. The distribution of λi=1...K1 is from one instant
of the inner loop of Alg I. The K1 parameter was set at 10000 and K2 was set to 1000.
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Figure 4.21: Two dimensional visualization of avian H5 influenza virus evolution. The
old and new clusters are overlapped and there is no distinct chronological directional
trend.
In late 1993, an outbreak of H5N2 influenza in poultry in Mexico was detected and
a long term vaccination program was implemented in hope to bring the outbreak under
control and to eradicate the virus [45, 4]. The vaccination program was in effect for
over 13 years but an increase in respiratory signs of disease was observed in vaccinated
chickens [4]. The suspected cause of this increase signs of disease was the antigenic
drifts occurred in the influenza viruses [86]. In other words, the vaccine strain used
in the vaccination program no longer matched the circulating strain in the field. The
vaccine strain (A/Ck/Mexico/CPA-232/1994) was isolated in early 1994 and has been in
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Figure 4.22: Avian H5 class label randomization simulation result. The green dot
represents the λo value (observed class separateness value). The blue line on the far left
of this figure represent the distribution of λi=1...K1.
used for the duration of the program for over a decade. Using the available genetic HA
sequences from these vaccinated chicken, we produced a 3 dimensional PCA plot (Figure
4.23) to show the evolution of the field isolates from 1994 to 2002. The first observation
from Figure 4.23 is that a directional evolutionary trend similar to other vaccinated
samples can be seen in this figure. Second, a chronological pattern is obvious indicating
that the virus had undergone constant evolution or antigenic drifted away from the early
strains. A split in the evolutionary path can be seen occurring in the 1990s. This split
or divergence has been reported in studies by [45, 4] based on phylogenetic analyses
conducted on the same sequence sample. The conclusions drawn from [45, 4] was that
cumulative genetic drifts in the HA gene provided an advantage in viral evolution and
that the diverged isolates were distinct from the vaccine strain used in the vaccination
program.
The Class-separateness analysis of the vaccine controlled avian H5 (Mexico) sample
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Figure 4.23: Avian H5 influenza virus (vaccinated sample) evolution from 1994-2002.
indicated that the observed class separateness value λo is at 1.7 which is quite far from
the mean of the distribution generated by using Alg I. compares to the λo value of the
non-vaccine controlled avian H5 sample. The distance in terms of standard deviation is
at 12.23±0.11 as shown in Figure 4.24. The distribution of λi=1...K1 is only one instant
from the inner loop of Alg I. The K1 parameter was set at 10000 and K2 was set to
1000.
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Figure 4.24: Avian H5 (vaccine controlled) class label randomization simulation result.
The green dot represents the λo value (observed class separateness value). The blue line
on the far left of this figure represent the distribution of λi=1...K1.
4.8 Discussion and Conclusions
From a visualization point of view, we can summarize the observations between vaccine
controlled influenza virus and nonvaccine controlled influenza virus as follows:
• Vaccine controlled seasonal human influenza
– Restricted directional evolution trend.
– Evolution follows a chronological pattern.
– Viruses cluster around vaccine strains.
– Clear separation between clusters.
– Narrow band of clusters along the directional evolution path.
– Clusters contain viruses with the same isolation year.
• Non-vaccine controlled influenza
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– Wider and overlapped clusters.
– Late clusters seem to be ’scattered’ around early clusters.
– No obvious chronological ordering of clusters.
– Clusters contain viruses span longer time period.
Apart from the genetic distance changes, each ’clump’ on the evolutionary path of
the virus can be identified by using the isolation year of the virus. This suggests that
the isolation year of the virus can be used as a class cluster label when computing the
cluster scatter for vaccine controlled and nonvaccine controlled influenza virus. The
hypothesis is that vaccine controlled viruses tended to cluster toward the yearly vaccine
seed strain for each season, thus leading to clusters contain viruses with the same iso-
lation year as observed in the PCA plot. Following this observation, we computed the
class or clusters separateness of seasonal A/H1N1, A/H3N2, influenza B Victoria and
Yamagata lineages, avian H5 (Mexico), avian H5, and human H5N1 influenza viruses
using the multi-class scatter matrix computation method for both the before and after
class labels randomization process. We performed 10000 runs of inner loop ”K1” from
Alg. I on both influenza sample groups (vaccine controlled and non-vaccine controlled).
The results from Alg I are shown in Table 4.2 and in Table 4.3 respectively. The ob-
served separateness measure λo of humans A/H1N1, A/H3N2, and Type B influenza are
consistently at a large distance from the mean of the empirical distribution generated
from Alg I. On the other hand, the observed separateness measure λo values of avian H5
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Sample λo Distance
A/H1N1 24.7 617.2± .04
A/H3N2 30.52 978.3± .031
Influenza B (Vic) 26.31 1310± .02
Influenza B (Yam) 25.38 1327.8± .019
Human H5N1 1.01 34.8± .029
Table 4.2: Multi-class scatter measurement results: For each human sample, we mea-
sured the ’clumpiness’ before and after randomization procedure. λo indicates the
clumpiness measurement before randomization. # of seqs is the number of sequences in
the dataset. Distance is the number of standard deviations λo is away from the mean
of the empirical distribution obtained from running Alg I.
Sample λo Distance
Avian H5(Mexico) 1.7 12.23± .11
Avian H5 0.268 3.16± .06
Table 4.3: Multi-class scatter measurement results: For each avian sample, we measured
the ’clumpiness’ before and after randomization procedure. λo indicates the clumpiness
measurement before randomization. # of seqs is the number of sequences in the dataset.
Distance is the number of standard deviations λo is away from the mean of the empirical
distribution obtained from running Alg I.
and human H5N1 influenza viruses (non-vaccine controlled) are close to the mean of the
empirical distribution. The area under the tail of the distributions beyond the observed
separateness values was below rounding error of 10−16 which made the computation of
p-value not possible. The large margin of difference in observed λ values between vac-
cine controlled and non-vaccine controlled samples indicated that there is a difference in
evolution between these two groups of influenza viruses. The class separateness analysis
results indicated that the vaccine controlled viruses showed much higher ’cohesiveness’
in each year than the viruses from non-vaccine controlled samples.
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Figure 4.25: Singular Value Decomposition. X is the data matrix with rows as strains
and columns as residues.
Vaccination is the principal measure for preventing influenza and reducing its im-
pact [133, 134]. Almost a century ago after the isolation of the first influenza virus,
influenza vaccines have been persistent and have evolved to respond to the evolution of
the influenza viruses evolving in humans [135, 136]. Antigenic drift of influenza viruses
occurs frequently among circulating strains that leads to new antigenic variants. How-
ever, whether the drift mechanism occurs with the presence of vaccine pressure is an
important question that needs to be addressed at different level as vaccination is the
primary method in prevention and protection for humans against influenza virus. Two
studies [65, 45] have shown that vaccination forces mutations on the HA protein of
the influenza virus. These mutations changed the way in which the virus gradually
evolved and adapted to a new vaccine protected environment. Here, we extended the
spectrum of analysis to include vaccine controlled seasonal human influenza viruses and
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nonvaccine controlled influenza viruses in avian and human in order to provide a wider
picture of the evolution dynamics of the virus in difference environments. The restricted
directional evolutionary trends and clusters formation around the vaccine strains along
the evolutionary paths exhibited by the vaccine controlled influenza viruses are in sharp
contrast to the nonvaccine controlled influenza viruses. Apart from this distinction, the
naturally emerged chronological ordering of vaccine controlled influenza viruses in the
PCA plots is much more noticeable than the nonvaccine controlled viruses. This natural
chronological ordering reflects the active adaptation of the viruses to their changing en-
vironment. The ’clumpiness measure’ exposes the fact that vaccine controlled influenza
viruses that share the same isolation year have the tendency to cluster tightly together
or form narrow bands. The narrow bands indicate the gradual changes of the genetic
composition of the functional sites of the HA surface protein. In contrast, nonvaccine
controlled influenza viruses isolated within the same time period appeared to be more
scattered and the clusters exhibited much larger within cluster distance with no narrow
restricted bands being observed. These observations suggested that the mutations on
the HA gene were not restricted to certain sites alone and that the majority of these mu-
tations most likely were synonymous nucleotide substitutions on the HA gene. Also, the
number of clusters observed are almost identical to the number of vaccine updates for
the seasonal human A/H3N2 and influenza B viruses. The number of clusters observed
in the seasonal human A/H1N1 is not the same as the number of vaccine updates but
it does show the fact that this virus has been gradually evolving away from the vaccine
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strains as time passes. Since the A/H1N1pdm09 pandemic strain replaced the A/H1N1
strains in 2009 as the H1N1 vaccine component, the virus can be seen as slowly evolving
but has not changed to a new antigenic variant.
The very low value of λo computed from nonvaccine controlled influenza viruses has
clearly captured the fact that these groups of viruses are not actively evolving by the
year. In contrast, the vaccine controlled influenza viruses have been actively evolving
and adapting to the changing environment constantly as new vaccine composition is
being introduced almost every year. This is clearly reflected in the very high λo value
for vaccine controlled influenza viruses. In addition, the cohesiveness of strains in each
year in vaccinated samples are much higher than the strains from nonvaccinated sam-
ples as suggested by the Alg I results. Although our analysis was based on genetic
sequences alone, the results suggested that a clear difference existed among influenza
viruses evolving in a vaccine protected environment than in the wild. This difference
is shown through the multi-class scatter computation of their evolutionary paths. This
quantitative measurement also serves as a basic statistical support to the observed dif-
ferences in the evolution dynamics between vaccine controlled and nonvaccine controlled
influenza viruses.
There are other potential factors besides vaccination that can affect the evolution
of influenza viruses, such as host specific immune response, the large difference in life
expectancy between humans and avian species, vaccine efficacy and effectiveness, the
transmission channel of the virus in difference environment, and geographical regions.
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These factors have not been considered in this present study because our overall objec-
tive is to present a genetic sequence only approach as the first step in understanding
the evolution of influenza viruses in protected and wild environments. Our approach
works directly at the sequence level with no prior assumption about the evolution of
the virus. It is a departure from traditional one dimensional phylogenetic approach in
that we visualize influenza evolution in 2D and 3D space. All phylogenetic methods
make or rely heavily upon the assumptions about underlying evolutionary process [90].
By using methods that avoid making assumptions about the parentage relations among
the strains, we can avoid possible misinterpretation of the results. As has been shown
in this paper, a data driven approach with no prior assumptions about the evolution
of the influenza virus affords us a different perspective in directly visualizing how the
virus evolves in a span of over half a century. This perspective has given us insight
into the way we think about the driving forces behind the emergence of human seasonal
influenza antigenic variant strains season after season. Perhaps, vaccination did play a
role in forcing the virus to undergo a different evolutionary path in order to continue to
establish itself in its occupied host. A definitively scientific conclusion cannot be drawn
without a thorough study of the virus in a controlled experiment for an extended period
of time which should no less to include multiple influenza epidemics in humans.
Chapter 5
Influenza Reassortant Prediction
5.1 Introduction
In this chapter, we propose a method to find influenza reassortant candidates among a
large collection of strains represented by their genetic sequences. The proposed method
is based on visual inspection of all eight genome segments of the virus simultaneously
on a single scatter plot.
In April 2009, a novel swine reassortant caused a global pandemic [137]. The segmen-
tal content of the genome was traced to be originated from different lineages. Trifonov,
V.[138, 139] confirmed that this pandemic reassortant virus consisted of six internal
gene segments (PB2, PB1, PA, HA, NP and NS) from the triple-reassortant swine
H3N2 North American swine lineage and M and NA gene segments descending from
a Eurasian lineage of swine influenza virus. The exchange of gene segments between
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two or more influenza viruses resulting in the production of reassortant viruses is called
the reassortment process and is termed antigenic shift (see section 1.6.1) when the sur-
face HA and NA genes are swapped that resulting in a new antigenic subtype [11] of
influenza. A new subtype of influenza can lead to a potential pandemic outbreak if
transmitted effectively among humans since humans have no prior immuno capability
to fight the new subtype.
The detection of reassortant virus is difficult [140] as many virus lineages co-exist
among mammalian and avian hosts. Yet, the understanding of the influenza virus evolu-
tion at the genomic scale is vital to shed light on the inter-relationship between different
lineages that generate reassortment events. Therefore, in order to successfully identify
reassortant virus, the problem becomes to identify the lineage origin of emerging novel
strains. Given the genetic diversity (16 subtypes) and the numerous virus lineages exist
and are co-circulating in human, swine, and avian populations; it is a daunting task and
a huge challenge to pinpoint the lineage origin of a flu virus. On a crude level, one can
first use BLAST [141] to search the NCBI Influenza Virus [6] sequence database to iden-
tify the most recent ancestors of the query sequence. Then one can use a phylogenetic
analysis to perform a one to one gene segment comparison to resolve small sequence
polymorphism in order to assign a specific lineage for the query sequence [142, 143].
There are two immediate challenges one faces in tracing the lineage origin of a virus.
One, the complete genome sequence for historical strains and recent circulating strains
are limited, and often not all their eight segments have been completely sequenced and
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made available in the database. Two, if phylogenetic analysis is to be utilized, separate
tree needs to be built for each gene segment. Even though this is the most accepted
method, it depends on the underlying tree building algorithm. In addition, correct ref-
erence sequences need to be used when constructing trees to identify reassortant virus.
This reference sequence set usually can be collected by using previously reported strains
in the literature. Presently, there is no gold standard reference influenza genomic dataset
available specifically for influenza reassortant detection.
5.2 Background
The three most recent pandemics (1957, 1968, and 2009) have been caused by reassor-
tant influenza A strains [144]. Given the segmented genomic structure of the influenza
virus, a progeny virus can inherit gene segments from two different subtypes of the in-
fluenza viruses during co-infection and replication [145, 146, 147]. Historically, the main
focus has been on the two segments (4 and 6) which encode the HA and NA surface
proteins when detecting reassortment events between subtypes. This is because the an-
tibodies from human immunity system cannot recognize the new surface proteins from
a reassorted virus immediately, and this can result in a pandemic outbreak. Therefore,
identification of new reassortants is important in understanding the evolution of the
virus and can help set early warning sign when reassortants are detected.
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Phylogenetic tree analysis [148, 143, 149, 150] has been used as the main com-
putational method to detect reassortant influenza viruses. In order to detect reas-
sortant influenza virus using phylogenetic trees, the assumption has been to look for
the tree topology discrepancy between trees built for each influenza genome segment.
This is because reassortment event has caused the topology to be different. However,
the topology difference can also be caused by phylogenetic construction errors. Alter-
native computational approaches have been proposed to detect influenza reassortants
[151, 147, 152, 153]. In [151], full influenza genome nucleotide sequence was utilized
with each segment’s closest neighbors calculated using Phylip software with the Jukes
Cantor evolution model. The calculation of ’closest’ neighbor gives the genetic distance
matrix for all pairs of strains and segments. A comparison analysis of the neighbors
for each segment is then utilized to identify the number of common neighbors for each
segment. The higher the number of common neighbor strains for each segment, the
more likely that the test strain is not a reassortant virus. If there are very few common
neighbors for the segment, then the test strain is likely to be a reassortant virus.
5.3 Method
In this section, we outline the proposed reassortant detection method and demonstrate
its usefulness by presenting the results from analyzing full genome sequences of influenza
viruses.
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5.3.1 Data Processing
Influenza genome sequences were downloaded from NCBI influenza database [6]. Each
downloaded full genome nucleotide sequence contains eight segments (PB2, PB1, PA,
HA, NP, NA, M, NS) which are different in length (refer to chapter 1 for the length of
each segment). Each segment was pre-processed by converting to a binary string [95].
After the binary conversion, each segment is collected into a matrix A with the longest
string as the column dimension of A. 0 is appended to the shorter binary strings so
that all eight binary strings will have the same length.
5.3.2 Reassortants Detection
A special feature of the Principal Component Analysis (PCA) is the capability to project
high dimensional data points onto a low dimension space. This is special because the
computed principal components from the data points can be ’reused’ for future data
points. We take advantage of this ’reusability’ of the PCA components to help in
identifying influenza reassortants. The computation of the principal components can
be carried out by using Singular Value Decomposition (SVD) algorithm as described in
Chapter 4.4.2.
The influenza reassortant method developed here can be viewed as a three-step
process. First, we compute the principal components V of the training data points in
the binary data matrix A. Second, we apply a pre-processing step to the new testing
data points in binary matrix X. The pre-processing is needed in order to make sure
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that the training and testing data are consistent in scale. Three, the projection of the
pre-processed new data points Xˆ is accomplished through Xˆ × V . For example, given
the new data points in matrix X of size mˆ by n, one must first center the new data
matrix by subtracting the column mean from each column of X. Here, the column
mean to be subtracted is the column mean from the training data matrix A. This is
to ensure that the new data points undergo the same ’pre-processing’ as the old data
points before projection. Once the new data points are centered, the projection can be
performed simply by Xˆ ∗V and the resultant matrix has the dimension of mˆ by 2. Once
the projection of the new/testing data is completed, if no reassorted gene segment is
present in the testing virus, one sees eight pairs of gene segments (ie. HA segment of
reference virus pairs with HA segment of testing virus) on the scatter plot.
5.3.3 Automated detection
Although the visualization of the genome segments in a two dimensional space gives a
clear view of the relationship between the test virus and the reference virus’s genome
segments, one can improve this approach by providing a simple automatic method
in with simple pairwise distance measure can be used to detect reassorted genome
segments. The assumption here is that if two gene segments are from the same lineage,
their genetic composition should have a high degree of similarity and should exhibit
a very small distance between each other in the 2D space graph. On the other hand,
if two gene segments are from two different lineages, then their genetic composition
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should show a low degree of similarity and produce a large distance between each other
in the plot. The simple method is to compute the pairwise distance between each
genome segment of the test and reference viruses using the PCA coordinates of each
genome segment. An 8− by−8 pairwise distance matrix can be easily obtained and can
then extract the diagonal elements of this matrix to inspect the distance between each
genome segment. The diagonal elements of this matrix gives the distance between the
pairings of the gene segments in the PCA plot. This is because we are only interested in
the pairings of the same genome segment between the test and reference virus genomes.
One factor that needs to be addressed is a cutoff value for the pairwise distance. This
cutoff value indicates whether the pair of gene segment is ’close’ to each other or far
away from each other. If the gene segments are below this cutoff value, then we say
that their pairwise distance is small and that they are similar. On the other hand, if the
gene segments are above the cutoff value, then we say that this pair is far away from
each other and thus are from different parental strains or lineages. The cutoff value
acts as a threshold value or cutoff for the minimum distance between each pair of gene
segment that is needed in order to capture the separation between two gene segments
on the PCA 2D space. The selection of the cutoff value can be determined by the mean
of pairwise distance matrix. Given that the genetic composition of two viruses from the
same lineage can have small variation due to synonymous substitutions, using the mean
pairwise distance as cutoff should allow for some flexibility to account for this type of
difference between two virus genomes.
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5.4 Results
5.4.1 Swine influenza H3N2 Reassortant Virus
In 1998, a double reassortant influenza virus A/Swine/North Carolina/35922/98(H3N2)
was isolated in North Carolina swine farm. This double reassortant virus [154] was
found to have gene segments (PB2, PA, NP, M, NS) from classical swine H1N1 lineage
combined with gene segments (PB1, HA, NA) from a human seasonal H3N2 influenza
virus [155]. This North American swine H3N2 strain carried gene segments from two
different lineages. The classical swine H1N1 lineage is closely related to the 1918 H1N1
Spanish flu virus and other human influenza viruses isolated in the 1930s [68]. The
surface genes HA and NA (segment 4 and segment 6) and internal gene segment 2 (PB1)
came from the seasonal human H3N2 lineage which had been circulating in humans since
1968. The rest of the gene segments came from classical swine influenza virus [68]. The
’pairing’ of these gene segments is shown in Figure 5.1.
A reassortant virus H3N2 A/SW/CO/77 genome sequence identified in [156] to test
the predictive power of our approach. We selected this isolate because its genetic char-
acterization by [156] using phylogenetic trees indicated that A/SW/CO/77 pig isolate’s
HA and NA proteins are closely related to the human influenza virus. In this second
analysis, we conducted two tests: an experiment test and a control test. For the ex-
periment test (result shown in figure 5.2), we first computed the principal components
using field isolates of human origin flu viruses (see Materials and Methods for human
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Figure 5.1: A swine H3N2 double reassortant virus (blue) isolated in North Carolina in
1988. The red circles are the classical swine H1N1 gene segments and the blue ’crosses’
are the gene segments of the swine H3N2 double reassortant virus. Segments 2 (PB1),
4 (HA), and 6 (NA) of this reassortant virus were from human seasonal H3N2 influenza
virus and the rest of its gene segments were from classical swine lineage. Each gene
segment is numbered from 1 to 8. Segment 2, 4, and 6 of the reassortant virus do not
overlap with the same gene segments from the classical swine H1N1 virus.
virus genomes used) and then projected the A/Swine/CO/77 genome onto these pre-
computed principal components. We see that the HA and NA proteins of A/SW/CO/77
are closely ”attached” to the human HA and NA counterparts, which suggests that these
two surface proteins were originated from a human-host type virus during reassortment
event.
For the reference/control virus (result shown in Figure 5.2 and Figure 5.3), we se-
lected the H3N2 A/swine/Wisconsin/2/1970 swine virus as the control genome because
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Figure 5.2: SW/CO/77 genome projected onto principal components computed using
human origin flu viruses genomes. Green dots represent the Human HA and NA surface
genes, red dots are the SW/CO/77 genes, and blue dots are the internal genes from
human host genome.
A/SW/CO/77 was isolated in 1977. The reason for selecting a 1977 strain as a control
is that the swine flu virus lineage at that time had not diverged into multiple lineages
that carried gene segments with mixed host type [156]. This is also to assure that the
control strain contains only gene segments from a single host type of swine origin. Based
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Figure 5.3: SW/CO/77 genome projected onto principal components computed using
swine virus genome as reference. Red dots represent A/SW/CO/77 genes and blue dots
represent the reference virus A/Swine/Wisconsin/ genes.
on phylogenetic analysis, A/swine/Wisconsin/2/1970 does not contain foreign host type
gene. We pre-computed the principal components using the control genome sequence
and then projected the A/SW/CO/77 genome onto the first two components. Clearly,
we can see that A/SW/CO/77 strain’s HA and NA proteins (red dots) are clearly dis-
tantly apart from the swine origin counterparts (blue dots). From the results of these
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two reassortant detection tests, we can see that there is an unique feature or a signature
pattern that represent each specific host type. With the right feature representation,
PCA can quickly isolate and identify these type of attributes in the dataset.
5.5 Discussion and Conclusions
Identification of reassortment events is neither trivial nor straightforward. The identi-
fication process can usually be divided into a three step procedure. One, multiple se-
quence alignment of reference sequences with test sequence is usually performed. Two,
phylogenetic tree construction for all eight segments using the aligned sequences. Three,
identify conflicting tree topologies between gene segments as the potential reassortment.
Selecting reference sequences is not a straightforward task in itself. The choice of ref-
erence sequences can have significant impact on the result of the reassortment identi-
fication. A reassortment event is more easily detected if the two strains involved in
producing the reassortant are sufficiently divergent in their sequences. Reassortment
between very similar strains is likely to go undetected by most, if not all, methods.
The influenza reassortants detection method presented in this chapter is based on
visual inspection of eight influenza gene segments simultaneously on a single scatter plot.
The assumptions we made in this approach is that if two influenza viruses have the same
evolution history, their gene segments should have high degree of genetic similarity and
that the segment length should be the same. These assumptions are consistent with the
approach taken by Rabadan et al.,[157] in that they suggested that the evolutionary
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rate of gene segments should remain the same if two viruses share the same evolution
history.
The proposed method avoids using multiple sequence alignment and phylogenetic
tree approaches because the objective of reassortant detection or identification is to
discover ’immediate genetic changes’ within the influenza virus genome when gene seg-
ments comparisons are made to any existing circulating strains. The heuristic results
from multiple sequence alignment (MSA) and phylogenetic tree construction are often
based on underlying evolutionary assumptions. Previous studies have shown most of
the available MSA methods only have accuracy of less than 70 percent, and even as low
as 40 percent [158]. Because the mechanisms behind the preferential reassortments are
still not completely understood, it is our believe methods to detect reassortment events
can benefit from relying on the signal in the data instead of underlying evolutionary
process assumptions.
Chapter 6
North American Swine H3N2
Influenza
6.1 Introduction
In this chapter, we present the results using method developed in chapter 4 to study the
North American swine H3N2 influenza viruses. Based on our computational analysis
of the genetic information of the hemagglutinin gene, we identified 2 hemagglutinin
amino acid residues positions 142 and 144 have led to the formation of the distinct pre-
and post-2009 clusters and could potentially act as a cluster signature to identify future
swine A/H3N2 virus. Recent H3N2v exclusively clustered into a post-2009 cluster which
consists of swine influenza viruses from Ohio agricultural fairs.
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6.2 Background
Three main subtypes of influenza virus (H1N1, H3N2, and H1N2) are circulating in
domesticated swine populations around the world. In 1998, H3N2 virus was isolated in
pigs in North Carolina, Minnesota, Iowa, and Texas [155] with gene segments similar
to those of human (HA, NA, and PB1) and classic swine (NS, NP, and M), and avian
(PB2 and PA) lineages. This triple reassorted virus has been circulating in the US
swine population since 1998, and in 2010 a new variant that contained a matrix gene
of the 2009 A(H1N1)pdm09 virus was first identified in U.S. pigs [159]. Swine influenza
surveillance has intensified since the pandemic of 2009 caused by swine origin H1N1
leading to multiple sequence submissions made available for study. Previous studies
[160, 161, 18] have demonstrated that different swine A/H3N2 influenza virus clusters
were emerging in the U.S. swine populations.
The emergence of these post-2009 swine A/H3N2 influenza clusters can potentially
lead to the steady increase of the swine A/H3N2 influenza virus diversity in North
America. It is therefore important to identify any potential cluster signature that can
quickly determine the cluster origin of the virus and to allow for more effective mon-
itoring of its evolution. We therefore hypothesize that the genetic information on the
hemagglutinin surface gene is sufficient to define the cluster diversity of the HA gene
segments. Here, we show that using computational techniques, variation in two amino
acid residues of the HA gene is sufficient to explain the existing cluster diversity among
swine influenza A/H3N2 virus in North America.
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6.3 MATERIALS AND METHODS
6.3.1 Sequence data
A total of 816 U.S. swine influenza A/H3N2 virus hemagglutinin nucleotide and protein
sequences from 1999 to 2013 available from NCBI influenza database [6] were down-
loaded for our study. Majority of the sequences represent collections from Illinois,
Minnesota, Indiana, Iowa, Michigan, Nebraska, North Carolina, Ohio, Pennsylvania,
Texas, Wisconsin, and Wyoming over a period representing the years of 2009 to 2013.
We also included representative strains of the classic swine clusters I,II,III, and IV in
our dataset. Eight H3N2v virus hemagglutinin sequences from Indiana, Iowa, Maine,
Pennsylvania, and West Virginia isolated in year 2011 were also included in the analysis.
6.3.2 Methods
6.3.3 Multiple sequence alignment and conversion
Multiple sequence alignment on all sequences were performed using NCBI multiple
sequence alignment tool [6] using default parameters. All sequences were digitized to 0
and 1 values that directly enables a binary sequence analysis as detailed in Chapter 4 of
this thesis. The processed sequence data was then visualized using the high dimensional
reduction method found in Chapter 4 and in [95].
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6.3.4 Weight assignment
In order to identify the positions on the HA gene that contribute the most to the
clustering, we also computed a weighted PCA with each site weighted by its variability.
The variability of each position is shown in Figure 6.1. Given the aligned HA protein
sequences, the weight ω which measures the variability of each HA position is obtained
by computing its columnwise Shannon entropy H(Y ) [162] where Y is a discrete random
variable with alphabet Λ of twenty amino acids. The probability Pij is estimated as the
observed fraction of each amino acid in position j that equals Pij =
1
m
∑m
l=1 I(Ylj = yi)
where Yij is amino acid in strain l position j, an I()˙ is the indicator function. The
Shannon entropy at j is Hj(Y ) = −
∑20
i=1 Pj(yi) log2 Pj(yi) for j = 1, ..., n. The weight
ωj is then assigned to the diagonal element of a diagonal weight matrix W of size n
by n. A high weight or high variability position may indicate an antibody binding site
that is under immune pressure. A low weight or low variability position may correlate
to structurally conserved site that is responsible for maintaining the core functionality
of the protein. Each column of X corresponding to position j was multiplied by ωj , j =
1, ..n.
6.3.5 Phylogenetic analysis
Phylogenetic analysis of the amino acid sequences of the swine influenza A/H3N2 virus
HA gene using the Mega 5.0 software [163, 164] to generate neighbor-joining phylogenetic
tree (Figure 6.2) from the dataset with 1000 bootstrap replications to verify the tree
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Figure 6.1: HA weight distribution computed using Shannon entropy formulation. Po-
sition 142 and 144 (H3 numbering) have entropy value of 1.609 and 1.302 respectively.
topology was performed. The model used was the maximum composition likelihood
model with gamma distribution parameter set to 1.
6.4 RESULTS
6.4.1 Clustering analysis
Five distinct clusters of the U.S. swine influenza A/H3N2 virus were produced using the
K-means algorithm [52] on the 3D projection data generated based on PCA algorithm.
These five distinct clusters are well separated in the PCA 3D space (Figure 6.3). Figures
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Figure 6.2: North American swine influenza H3N2 virus phylogenetic tree. The color
coded branches correspond to the clusters observed in Figure 6.3
6.4 and 6.5 illustrated the clusters by virus isolation year and isolation location. The
four-post-2009 clusters are the A, B, C, and E which contain contemporary (2009 - 2013)
swine A/H3N2 virus [18]. Cluster D consists of pre-2009 swine influenza A/H3N2 viruses
that have been circulating in U.S. between 1998 and 2008 and the Canada originated
swine influenza ”cluster IV” virus [165]. Viruses in cluster E show the highest genetic
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similarity with maximum 6 amino acids difference. The most diverse cluster is the pre-
2009 cluster D with maximum amino acid difference of 144. This is not surprising as this
cluster contains viruses from the historic swine H3N2 viruses in the U.S. that emerged
from the three clusters of [165] derived from three distinct human seasonal H3N2 virus
from 1995, 1997 and 1996 and the ”cluster IV” viruses from 2006 respectively [154, 166].
In addition, HA gene of the four post-2009 clusters A, B, C, and E exhibited far less
diversity compared with cluster D judged by the viruses pairwise within cluster distance.
Cluster A consists of all the isolates from Ohio agricultural fairs from years 2010, 2011,
and 2012. On the other hand, cluster E consists of all 2009 Ohio agricultural fairs
isolates. This finding is consistent with study on recent North American swine influenza
A/H3N2 viruses performed by Feng et. al 2013 [161] in which they had shown that 2009
Ohio agricultural fairs isolates were antigenically different than the 2010 and 2011 fair
isolates. Cluster C (Red) contains isolates from Iowa, Minnesota, Illinois, Nebraska,
Texas and South Dakota from year 2011 and 2012. Cluster B (Blue) contains isolates
from Illinois, Iowa, Minnesota, and South Dakota from year 2012. This suggests that
neither geographical locations nor year of virus isolation played a role in virus diversity.
The most likely explanation is that each cluster reflects a group of antigenically distinct
group of viruses that are emerging in the U.S. swine populations. It is not uncommon
to find multiple antigenic groups within the same geographical location within the same
year.
In July 2011, an influenza H3N2v virus that normally circulates in pigs were found
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Figure 6.3: North American swine influenza H3N2 virus clusters.
in humans in Indiana, Iowa, Maine, Pennsylvania, and West Virginia. The virus carries
the matrix (M) gene from the 2009 H1N1 pandemic virus. In 2012, 307 cases of H3N2v
infection were detected in U.S. from 11 states [167, 168]. Using the projection from
the unweighted PCA, all available H3N2v isolates from Indiana were projected into
different clusters (Figure 6.6). These H3N2v virus and the clustered viruses share the
same cluster signature residues at position 142 and 144 respectively.
In order to determine all the changes that led to the clustering pattern produced, we
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Figure 6.4: PCA projection of 2013 swine H3N2 influenza virus (blue). Viruses are
colored by isolation years.
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Figure 6.5: North American swine H3N2 influenza viruses by geographical locations.
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Figure 6.6: PCA projection of 2013 swine H3N2v influenza virus.
used the Shannon Entropy weighting scheme to yield a weighted PCA. The weights are
shown in Figure 6.1 and weighted PCA in Figure 6.7. The same clustering pattern was
produced when using the phenotype information of the influenza A/H3N2 virus with
weighting for each HA position. This indicated that variability of the positions played
a key role in forming the five distinct clusters observed. We then proceeded to identify
the positions responsible to the formation of these five distinctive clusters. Based on the
weighting value of each position, we selected position 142 (H3 numbering) within the
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antigenic site B which shows the highest variability and reconstructed the data matrix
using only phenotype information from this position and computed the weighted PCA.
Using this position alone, we were able to reproduce the same clustering pattern (Figure
4) observed in Figure 1. Further, when both the weight values of residue position 142
and 144 (second highest entropy value) were used, we also were able to reproduce the
same clustering pattern seen in Figure 1. This suggested that the variability present in
these two positions is more than sufficient to classify the virus into difference clusters.
At HA residue position 142 (antigenic site B), cluster A has glycine (Gly), cluster B has
glutamic (Glu), cluster C has asparagine (Asn), cluster D has arginine (Arg) or serine
(Ser), and cluster E has lysine (Lys) respectively. At residue position 144, cluster A
has valine (Val), cluster B has aspartic (Asp), cluster C has Valine (Val), cluster D has
isoleucine (Ile), or aspartic (Asp), or phenylalanine (Phe), and cluster E has glycine
(Gly) respectively. The combination of the residues 142 and 144 can form a useful
cluster signature or biological marker to designate each individual cluster and can be
used to quickly classify swine A/H3N2 virus. For example, cluster A has the Gly-Val
signature and cluster B has the Glu-Asp signature. Residue 142 is located on the loop
of the HA near the receptor-binding pocket. A mutation at this position may contribute
to a shift in receptor binding specificity [169, 170]. Residue 144 is located on the solvent
exposed surface of the HA globular head [65, 171] and has been shown to influence the
generation of escape mutants due to its glycosylation property [171].
125
−5
0
5
−6−4
−20
24
6
−4
−2
0
2
4
 
One
Two
 
T
h
re
e
Weighted PCA clusters
Original PCA clusters
B
D
E
C
A
Figure 6.7: Weighted PCA clusters and unweighted PCA clusters.
6.5 DISCUSSION
The influenza A virus can represent a great health concern for the public if not closely
monitored. We have shown that the North America swine influenza A/H3N2 virus can
be clustered into distinct pre- and post-2009 clusters. Given that pigs are thought to be
the mixing vessel for the influenza A virus, reassortant virus originated from pigs with
potential highly infectious and human transmissible characteristic can emerge without
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warning. It is therefore necessary and important to closely monitor the evolution of
the virus. Using computational techniques, we have shown that four post-2009 distinct
clusters of swine A/H3N2 virus are emerging in the U.S. swine populations and that the
combination of hemagglutinin residues 142 and 144 (H3 numbering) led to the formation
of these clusters. There is a possibility that mutations on sites 142 and 144 are related
or compensatory to each other. In order to provide such scenario, one would have to
use a mutual information approach to determine if these two sites are dependent sites.
Phylogenetic analysis confirmed that these four post-2009 clusters are most likely
derived from the historic cluster (cluster D) of the swine A/H3N2 influenza viruses that
have been circulating in the U.S. since 1998. H3N2v swine isolated from humans in
Indiana clustered with cluster A in which both showed the same cluster signature of
Gly-Val combination at residues 142 and 144. Phylogenetic analysis of the HA surface
gene confirmed that the U.S. swine A/H3N2 influenza can be grouped into five separate
clusters with the four post-2009 clusters originated from the historical swine influenza
virus cluster (cluster D). Cluster E is restricted to only 2009 Ohio agricultural fairs
isolates and no other cluster contains this 2009 genetic variants, hence it is quite possible
that this E group virus is localized to Ohio exhibition swine in that year. In short, our
findings highlight the need to closely monitor epitope regions of the hemagglutinin gene
of influenza A viruses circulating in swine and the genetic sequence information of the
influenza virus can be of great importance to determine the cause of cluster formation.
Chapter 7
Conclusions
7.1 Summary of contributions
The preceding chapters of this thesis describe the computational analysis of the evolution
of influenza viruses. A major focus of this thesis has been the study of the evolution of
influenza virus under vaccine pressure. Other computational analysis techniques have
also been developed to study different aspects of the influenza virus evolution. The vast
number of influenza genetic sequences drives the need to develop tools that can allow
quick and easy interpretation of the sequenced isolates so that a better understanding
of the evolution of the virus can be achieved. The computational techniques developed
in this thesis can be viewed as a high throughput analysis approach to analyze genetic
sequences that are rapidly growing in size and quantity. The major contributions of
this thesis are listed below:
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• A compact markov model.
• Influenza virus and vaccine.
• Influenza reassortant detection based on PCA projection.
• Cluster determinant analysis of the North American swine influenza virus.
7.2 Compact markov model
A two-layered statistical constructed from a Markov Chain model and a Poisson process
is presented in chapter 3. The Markov model models the single point mutations and the
Poisson process models the occurrence of the mutations. The Markov model is compact
because we model the state transition based on the Hamming distance of the genetic
sequence. The number of states only depend on the length of the genetic sequence. This
is a much less complex Markov chain model than any current Markov chain models used
in molecular evolution simulation.
7.3 Influenza virus and vaccine
As cost effective sequencing technologies propel the growth of influenza sequence data
in quality and quantity, much can be revealed about the evolution dynamics of the
influenza viruses base on the analysis of their genetic sequences. As we continue to make
progress toward the understanding of the evolution of influenza virus through analyzing
sequence samples from around the world, a more detailed picture of how the influenza
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virus evolves under difference selective pressures will eventually emerge. At the present
time, our primary focus has been on the understanding of the evolution of influenza
virus under vaccine pressure. Vaccination programs are widely used around the world
in fighting seasonal human influenza virus in north and south hemispheres. However, in
order to provide protection, vaccine needs to be updated annually as influenza virus’s
surface protein HA undergoes constant antigenic drift that leads to immune escape
variants. This constant vaccine update in order to track the evolution of the virus
has given rise to the development of the universal vaccine [172, 173, 174, 175, 176]
which targets the internal proteins of the virus. Although vaccination is commonly
used in human population and its efficacy and effectiveness have been examined from
time to time, the effects of vaccination on the virus itself has not been actively studied.
The results presented in this dissertation research show that influenza virus evolves
differently when under vaccine pressure. The most striking result is the evolution of
the seasonal human influenza AH3N2 virus. This is also the most frequent updated
vaccine strain in the trivalent vaccine that is administered every year. On the other
hand, influenza virus evolving in the wild does not show the same evolution pattern as
the vaccine controlled influenza viruses. The observational differences of the evolution
patterns between vaccine controlled and nonvaccine controlled influenza viruses are
further analyzed using scatter matrix computational approach. The results from the
analysis indicated that their evolutionary trends or patterns are not the same and that
the yearly cohesiveness of viruses from vaccinated samples are much higher than viruses
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nonvaccinated samples. The observational differences can be generally summarized as
follows:
• Vaccine controlled seasonal human influenza
– Restricted directional evolution trend.
– Evolution follows a chronological pattern.
– Viruses cluster around vaccine strains.
– Clear separation between clusters.
– Narrow band of clusters along the directional evolution path.
• Non-vaccine controlled influenza
– Wider and overlapped clusters.
– Late clusters seem to be ’scattered’ around early clusters.
– No obvious chronological ordering of clusters.
Influenza vaccination is the most used method in protecting us from the virus but
it is also a problem that appears over and over again as the virus evolves continuously.
The evolution of influenza virus in a vaccinated environment is rarely studied and how
does the virus successfully escape vaccine induced immunity continuously have continue
to cast doubt on the effect and ’side effect’ of vaccination. In order to fully resolve this
problem, one must combine the understanding of the effects of vaccination have on the
virus and on its host respectively.
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7.4 Influenza reassortant detection method
The influenza reassortant detection method developed in this thesis is based on a visual
inspection approach to identify reassortant virus. The method is quick and simple be-
cause no phylogenetic trees construction for all the influenza gene segments is needed.
The detection method relies on the projection technique from Principal Component
Analysis in that the pre-computed principle components of a reference strain genome
is used as the ’reference’. The unknown or test virus genome is projected onto the
pre-computed principle components and the unknown/test virus projection is then vi-
sualized on the same PCA plot along with the reference genome. This method allows
for the visualization of all the influenza genome segments at once in a single plot.
7.5 Cluster analysis of North American swine influenza
virus
A computational analysis based on the methods developed in this thesis was undertaken
to study the genetic diversity of the North American swine influenza H3N2 virus using
the HA gene sequence data. At the time of study, five major clusters were found and
that each cluster has its own cluster signature that can be represented by using two
positions (142, 144) on the HA gene. The significant of these two positions suggests
that future isolates can be grouped into clusters based on the genetic bases at these
two positions. In other words, it can provide molecular signatures for monitoring future
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genetic diversity of the North American swine influenza H3N2 virus.
7.6 Future directions
In this part of the chapter, we provide some future directions that are meant to carry
this thesis research further.
7.6.1 Investigate other genome segments
Influenza A has 8 genome segments and we have so far studied segment 4 in this thesis.
The rest of the genome segments code for different proteins and have different functional
role. Method developed in this thesis can be easily extended to study their evolution
trend or trajectory.
7.6.2 Vaccine strain/New antigenic variant prediction
As the human seasonal influenza trivalent vaccine needs to be updated every year,
the decision in selecting the matching vaccine seed strain to the next season dominant
circulating strain can be difficult. As of now, the selection decision is based on results
from antigenic characterization and phylogenetic analysis of influenza isolates available
prior to the start of a new flu season. In other words, we are predicting the new antigenic
variants based on existing or older data for the new flu season. In order to successfully
predict the upcoming dominant circulating strains, it is imperative to first understand
the effects (see section 7.3) of vaccination has on the evolution of the virus itself. The
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next step is then to develop a computational framework that captures the effects of
vaccination.
We also need to consider the number of dimensions needed to give the best approx-
imation to the original ’signal’ in the data in order to successfully predict the emerging
new antigenic variants. A simple way to determine the number of singular values to use
is to inspect the singular values σ′s produced from the SVD algorithm (see 4.4.3). As
an example, we used the seasonal human influenza A/H3N2 virus dataset and generated
the first 10 singular values using the SVD algorithm. A sharp drop of the singular value
from the first to second principal component indicates that the first PC most likely can
capture the majority of variance in the dataset. However, from the 6th PC onward, the
drop off has been relatively level and this indicates that any higher principal compo-
nents retained after PC 6 are mostly noises in the dataset. In this example, the number
of dimensions that can capture the original ’signal’ without much noise should be 6.
7.6.3 Kernel PCA application
Standard PCA can only handle linear dimensionality reduction. However, if the given
data cannot be well represented by a linear subspace due to its complex structure, then
standard PCA will fail to capture any important signal from the data. In order to deal
with the complex nature of the data, Kernel PCA (KPCA) [177] has been developed
to allow us to perform nonlinear dimensionality reduction. To use KPCA, one needs
to select a proper kernel function to handle the sequence data, for example, the string
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Figure 7.1: Singular values from the seasonal human influenza A/H3N2 dataset.
kernel [178, 179]. Applying kernel PCA to influenza sequence data should should help
to reveal the hidden information at a finer resolution.
7.7 Final remarks
The rapid accumulation of the influenza genetic sequences in flu sequence databases
afford us a great opportunity to understand the evolution of the influenza virus. By using
the large number of genetic sequence data, prediction of new epidemics can be achieved
and realized in the near future. In addition, new hypotheses about the evolution of
influenza virus can also be developed or generated by studying these vast amount of
genetic sequence data. The vaccine strain selection problem can also be greatly benefited
from studying the signals hidden in the sequences. Although the future evolutionary
paths of the seasonal human influenza viruses are not completely known, the continuous
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surveillance of influenza virus in mammalian and in avian species should be able to bring
us a step closer in seeing any emerging trends or variants in the near future.
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